STOCK TITAN

[10-Q] SurgePays, Inc. Warrant Quarterly Earnings Report

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
10-Q
Rhea-AI Filing Summary

SurgePays, Inc. reported consolidated results and a June 30, 2025 balance sheet that show a marked decline in scale and liquidity. For the six months ended June 30, 2025 the company recognized $22.1 million in revenue, down from $46.5 million a year earlier, and a net loss available to common stockholders of $14.7 million, or $(0.74) per share. Cash and equivalents fell to $4.4 million from $12.8 million at the start of the period, and total assets declined to $15.2 million while total liabilities rose to $15.15 million, leaving stockholders equity at only $61,392.

Revenue mix shifted toward Point-of-Sale and Prepaid Services, which contributed $17.54 million (79.4%) of six-month revenue versus $5.11 million a year ago, while MVNO revenues fell to $4.56 million (20.6%). Management discloses substantial doubt about the company’s ability to continue as a going concern over the next twelve months and identifies plans to grow MVNO visibility, diversify Lifeline streams, and pursue platform and marketing initiatives.

SurgePays, Inc. ha comunicato risultati consolidati e uno stato patrimoniale al 30 giugno 2025 che mostrano un marcato ridimensionamento e una ridotta liquidità. Nei sei mesi chiusi il 30 giugno 2025 la società ha registrato ricavi per $22.1 milioni, in calo rispetto a $46.5 milioni dell'anno precedente, e una perdita netta attribuibile agli azionisti comuni di $14.7 milioni, ovvero $(0.74) per azione. La liquidità e gli equivalenti sono scesi a $4.4 milioni da $12.8 milioni all'inizio del periodo; le attività totali sono diminuite a $15.2 milioni mentre le passività totali sono aumentate a $15.15 milioni, lasciando il patrimonio netto degli azionisti a soli $61,392.

La composizione dei ricavi si è spostata verso i servizi Point-of-Sale e Prepaid, che hanno contribuito per $17.54 milioni (79.4%) dei ricavi semestrali rispetto a $5.11 milioni un anno fa, mentre i ricavi MVNO sono scesi a $4.56 milioni (20.6%). Il management esprime seri dubbi sulla capacità della società di continuare l'attività nei prossimi dodici mesi e indica piani per aumentare la visibilità dell'MVNO, diversificare le entrate Lifeline e perseguire iniziative relative alla piattaforma e al marketing.

SurgePays, Inc. informó resultados consolidados y un balance al 30 de junio de 2025 que muestran una notable reducción de escala y liquidez. En los seis meses terminados el 30 de junio de 2025 la compañía registró ingresos por $22.1 millones, frente a $46.5 millones del año anterior, y una pérdida neta atribuible a los accionistas comunes de $14.7 millones, o $(0.74) por acción. El efectivo y equivalentes cayó a $4.4 millones desde $12.8 millones al inicio del período; los activos totales se redujeron a $15.2 millones mientras que los pasivos totales aumentaron a $15.15 millones, dejando el patrimonio neto de los accionistas en apenas $61,392.

La mezcla de ingresos se desplazó hacia Point-of-Sale y servicios Prepaid, que aportaron $17.54 millones (79.4%) de los ingresos semestrales frente a $5.11 millones el año anterior, mientras que los ingresos MVNO cayeron a $4.56 millones (20.6%). La dirección manifiesta dudas sustanciales sobre la capacidad de la compañía para continuar como negocio en funcionamiento durante los próximos doce meses e identifica planes para aumentar la visibilidad del MVNO, diversificar las fuentes Lifeline y avanzar en iniciativas de plataforma y marketing.

SurgePays, Inc.는 2025년 6월 30일 기준 연결 실적과 재무상태표를 공개했으며, 그 결과 규모와 유동성이 크게 축소된 것으로 나타났습니다. 2025년 6월 30일로 끝나는 6개월 동안 회사는 $22.1 million의 매출을 기록했으며 이는 전년의 $46.5 million에서 감소한 수치이고, 보통주주에게 귀속되는 순손실은 $14.7 million, 주당 손실은 $(0.74)였습니다. 현금 및 현금성자산은 기간 초 $12.8 million에서 $4.4 million로 줄었고, 총자산은 $15.2 million로 감소한 반면 총부채는 $15.15 million로 증가하여 자본총계는 단 $61,392에 불과합니다.

매출 구성은 POS(Point-of-Sale) 및 선불(Prepaid) 서비스 쪽으로 이동하여 이들 서비스가 6개월 매출의 $17.54 million(79.4%)를 차지했고 전년의 $5.11 million에서 증가한 반면, MVNO 매출은 $4.56 million(20.6%)로 감소했습니다. 경영진은 향후 12개월 동안 회사의 계속기업 존속 가능성에 대해 중대한 의문을 표명했으며 MVNO 가시성 제고, Lifeline 수익원 다각화, 플랫폼 및 마케팅 이니셔티브 추진 계획을 제시했습니다.

SurgePays, Inc. a publié des résultats consolidés et un bilan au 30 juin 2025 montrant une nette contraction de l'activité et de la liquidité. Pour les six mois clos le 30 juin 2025, la société a enregistré des revenus de $22.1 million, en baisse par rapport à $46.5 million un an plus tôt, et une perte nette attribuable aux actionnaires ordinaires de $14.7 million, soit $(0.74) par action. Les liquidités et équivalents sont passés de $12.8 million au début de la période à $4.4 million; l'actif total a diminué à $15.2 million tandis que le passif total a augmenté à $15.15 million, laissant des capitaux propres de seulement $61,392.

La répartition des revenus s'est orientée vers le Point-of-Sale et les services prépayés, qui ont apporté $17.54 million (79.4 %) des revenus semestriels contre $5.11 million l'année précédente, tandis que les revenus MVNO ont chuté à $4.56 million (20.6 %). La direction exprime des doutes significatifs quant à la capacité de l'entreprise à poursuivre son activité au cours des douze prochains mois et expose des plans visant à accroître la visibilité du MVNO, diversifier les flux Lifeline et lancer des initiatives de plateforme et de marketing.

SurgePays, Inc. veröffentlichte konsolidierte Ergebnisse und eine Bilanz zum 30. Juni 2025, die einen deutlichen Rückgang von Größe und Liquidität zeigen. Für die sechs Monate zum 30. Juni 2025 erzielte das Unternehmen Umsatzerlöse von $22.1 Millionen gegenüber $46.5 Millionen im Vorjahr sowie einen auf Stammaktionäre entfallenden Nettoverlust von $14.7 Millionen bzw. $(0.74) je Aktie. Zahlungsmittel und Zahlungsmitteläquivalente sanken von $12.8 Millionen zu Beginn des Zeitraums auf $4.4 Millionen; die Gesamtaktiva gingen auf $15.2 Millionen zurück, während die Gesamtverbindlichkeiten auf $15.15 Millionen stiegen, sodass das Eigenkapital der Aktionäre nur $61,392 beträgt.

Die Umsatzstruktur verschob sich zugunsten von Point-of-Sale- und Prepaid-Dienstleistungen, die $17.54 Millionen (79.4%) der Halbjahresumsätze ausmachten gegenüber $5.11 Millionen im Vorjahr, während die MVNO-Erlöse auf $4.56 Millionen (20.6%) fielen. Das Management äußert erhebliche Zweifel an der Fortführungsfähigkeit des Unternehmens für die nächsten zwölf Monate und nennt Pläne, die Sichtbarkeit des MVNO zu erhöhen, Lifeline-Einnahmequellen zu diversifizieren und Plattform- sowie Marketinginitiativen voranzutreiben.

Positive
  • Point-of-Sale and Prepaid Services growth: increased to $17.54 million and represented 79.36% of six-month revenue, a clear shift in revenue mix
  • Successful near-term financing: proceeds from a convertible note payable of $6,000,000 provided material cash inflow in the period
  • Integration of ClearLine technology: acquisition of ClearLine Mobile assets (recorded consideration $2.5M) adds POS marketing and merchant engagement capabilities
Negative
  • Large net loss: $14.7 million loss for the six months ended June 30, 2025 reducing retained capital
  • Declining liquidity: cash and cash equivalents fell to $4.4 million and net cash used in operations was $13.08 million
  • Revenue decline year-over-year: total six-month revenue declined from $46.51 million to $22.10 million
  • Balance sheet stress: total liabilities of $15.15 million nearly equal total assets of $15.22 million, leaving only $61,392 in stockholders' equity
  • Going concern disclosed: management states substantial doubt about ability to continue as a going concern for the next twelve months
  • Concentration risk: MVNO receivables are highly concentrated in FCC-administered programs (81% of receivables), exposing results to regulatory and funding changes

Insights

TL;DR: Revenue halved, losses widened and liquidity weakened; operating cash burn and rising liabilities create material financial stress.

The six-month results show total revenue down roughly 52% year-over-year to $22.1 million and a net loss of $14.7 million, driving an accumulated deficit of $75.6 million. Cash decreased by $8.4 million to $4.4 million while net cash used in operations was $13.08 million for the period. Total liabilities rose to $15.15 million, nearly matching total assets of $15.22 million and leaving negligible equity. These dynamics indicate constrained runway absent additional financing or rapid operating improvements. The shift of revenue toward Point-of-Sale and Prepaid Services partially offsets MVNO declines but has not eliminated operating losses.

TL;DR: Management explicitly discloses substantial doubt about going concern; financing activity provides temporary relief but governance and concentration risks persist.

Management states it lacks sufficient cash for more than one year and explicitly identifies substantial doubt about going concern. The company obtained $6.0 million from a convertible note issuance during the period and generated $4.72 million net from financing, which reduced but did not eliminate liquidity pressure. Accounts receivable remain highly concentrated in FCC-administered programs and 81% of receivables are tied to those programs as of June 30, 2025, creating regulatory funding concentration risk. Prior impairments and a full valuation allowance on deferred tax assets further underscore downside scenarios. These factors are governance-relevant for stakeholder oversight and capital raising strategy.

SurgePays, Inc. ha comunicato risultati consolidati e uno stato patrimoniale al 30 giugno 2025 che mostrano un marcato ridimensionamento e una ridotta liquidità. Nei sei mesi chiusi il 30 giugno 2025 la società ha registrato ricavi per $22.1 milioni, in calo rispetto a $46.5 milioni dell'anno precedente, e una perdita netta attribuibile agli azionisti comuni di $14.7 milioni, ovvero $(0.74) per azione. La liquidità e gli equivalenti sono scesi a $4.4 milioni da $12.8 milioni all'inizio del periodo; le attività totali sono diminuite a $15.2 milioni mentre le passività totali sono aumentate a $15.15 milioni, lasciando il patrimonio netto degli azionisti a soli $61,392.

La composizione dei ricavi si è spostata verso i servizi Point-of-Sale e Prepaid, che hanno contribuito per $17.54 milioni (79.4%) dei ricavi semestrali rispetto a $5.11 milioni un anno fa, mentre i ricavi MVNO sono scesi a $4.56 milioni (20.6%). Il management esprime seri dubbi sulla capacità della società di continuare l'attività nei prossimi dodici mesi e indica piani per aumentare la visibilità dell'MVNO, diversificare le entrate Lifeline e perseguire iniziative relative alla piattaforma e al marketing.

SurgePays, Inc. informó resultados consolidados y un balance al 30 de junio de 2025 que muestran una notable reducción de escala y liquidez. En los seis meses terminados el 30 de junio de 2025 la compañía registró ingresos por $22.1 millones, frente a $46.5 millones del año anterior, y una pérdida neta atribuible a los accionistas comunes de $14.7 millones, o $(0.74) por acción. El efectivo y equivalentes cayó a $4.4 millones desde $12.8 millones al inicio del período; los activos totales se redujeron a $15.2 millones mientras que los pasivos totales aumentaron a $15.15 millones, dejando el patrimonio neto de los accionistas en apenas $61,392.

La mezcla de ingresos se desplazó hacia Point-of-Sale y servicios Prepaid, que aportaron $17.54 millones (79.4%) de los ingresos semestrales frente a $5.11 millones el año anterior, mientras que los ingresos MVNO cayeron a $4.56 millones (20.6%). La dirección manifiesta dudas sustanciales sobre la capacidad de la compañía para continuar como negocio en funcionamiento durante los próximos doce meses e identifica planes para aumentar la visibilidad del MVNO, diversificar las fuentes Lifeline y avanzar en iniciativas de plataforma y marketing.

SurgePays, Inc.는 2025년 6월 30일 기준 연결 실적과 재무상태표를 공개했으며, 그 결과 규모와 유동성이 크게 축소된 것으로 나타났습니다. 2025년 6월 30일로 끝나는 6개월 동안 회사는 $22.1 million의 매출을 기록했으며 이는 전년의 $46.5 million에서 감소한 수치이고, 보통주주에게 귀속되는 순손실은 $14.7 million, 주당 손실은 $(0.74)였습니다. 현금 및 현금성자산은 기간 초 $12.8 million에서 $4.4 million로 줄었고, 총자산은 $15.2 million로 감소한 반면 총부채는 $15.15 million로 증가하여 자본총계는 단 $61,392에 불과합니다.

매출 구성은 POS(Point-of-Sale) 및 선불(Prepaid) 서비스 쪽으로 이동하여 이들 서비스가 6개월 매출의 $17.54 million(79.4%)를 차지했고 전년의 $5.11 million에서 증가한 반면, MVNO 매출은 $4.56 million(20.6%)로 감소했습니다. 경영진은 향후 12개월 동안 회사의 계속기업 존속 가능성에 대해 중대한 의문을 표명했으며 MVNO 가시성 제고, Lifeline 수익원 다각화, 플랫폼 및 마케팅 이니셔티브 추진 계획을 제시했습니다.

SurgePays, Inc. a publié des résultats consolidés et un bilan au 30 juin 2025 montrant une nette contraction de l'activité et de la liquidité. Pour les six mois clos le 30 juin 2025, la société a enregistré des revenus de $22.1 million, en baisse par rapport à $46.5 million un an plus tôt, et une perte nette attribuable aux actionnaires ordinaires de $14.7 million, soit $(0.74) par action. Les liquidités et équivalents sont passés de $12.8 million au début de la période à $4.4 million; l'actif total a diminué à $15.2 million tandis que le passif total a augmenté à $15.15 million, laissant des capitaux propres de seulement $61,392.

La répartition des revenus s'est orientée vers le Point-of-Sale et les services prépayés, qui ont apporté $17.54 million (79.4 %) des revenus semestriels contre $5.11 million l'année précédente, tandis que les revenus MVNO ont chuté à $4.56 million (20.6 %). La direction exprime des doutes significatifs quant à la capacité de l'entreprise à poursuivre son activité au cours des douze prochains mois et expose des plans visant à accroître la visibilité du MVNO, diversifier les flux Lifeline et lancer des initiatives de plateforme et de marketing.

SurgePays, Inc. veröffentlichte konsolidierte Ergebnisse und eine Bilanz zum 30. Juni 2025, die einen deutlichen Rückgang von Größe und Liquidität zeigen. Für die sechs Monate zum 30. Juni 2025 erzielte das Unternehmen Umsatzerlöse von $22.1 Millionen gegenüber $46.5 Millionen im Vorjahr sowie einen auf Stammaktionäre entfallenden Nettoverlust von $14.7 Millionen bzw. $(0.74) je Aktie. Zahlungsmittel und Zahlungsmitteläquivalente sanken von $12.8 Millionen zu Beginn des Zeitraums auf $4.4 Millionen; die Gesamtaktiva gingen auf $15.2 Millionen zurück, während die Gesamtverbindlichkeiten auf $15.15 Millionen stiegen, sodass das Eigenkapital der Aktionäre nur $61,392 beträgt.

Die Umsatzstruktur verschob sich zugunsten von Point-of-Sale- und Prepaid-Dienstleistungen, die $17.54 Millionen (79.4%) der Halbjahresumsätze ausmachten gegenüber $5.11 Millionen im Vorjahr, während die MVNO-Erlöse auf $4.56 Millionen (20.6%) fielen. Das Management äußert erhebliche Zweifel an der Fortführungsfähigkeit des Unternehmens für die nächsten zwölf Monate und nennt Pläne, die Sichtbarkeit des MVNO zu erhöhen, Lifeline-Einnahmequellen zu diversifizieren und Plattform- sowie Marketinginitiativen voranzutreiben.

false Q2 --12-31 0001392694 0001392694 2025-01-01 2025-06-30 0001392694 2025-08-13 0001392694 2025-06-30 0001392694 2024-12-31 0001392694 us-gaap:NonrelatedPartyMember 2025-06-30 0001392694 us-gaap:NonrelatedPartyMember 2024-12-31 0001392694 us-gaap:RelatedPartyMember 2025-06-30 0001392694 us-gaap:RelatedPartyMember 2024-12-31 0001392694 SURG:SBAGovernmentMember 2025-06-30 0001392694 SURG:SBAGovernmentMember 2024-12-31 0001392694 2025-04-01 2025-06-30 0001392694 2024-04-01 2024-06-30 0001392694 2024-01-01 2024-06-30 0001392694 us-gaap:CommonStockMember 2024-12-31 0001392694 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001392694 us-gaap:RetainedEarningsMember 2024-12-31 0001392694 us-gaap:TreasuryStockCommonMember 2024-12-31 0001392694 us-gaap:NoncontrollingInterestMember 2024-12-31 0001392694 us-gaap:CommonStockMember 2025-03-31 0001392694 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001392694 us-gaap:RetainedEarningsMember 2025-03-31 0001392694 us-gaap:TreasuryStockCommonMember 2025-03-31 0001392694 us-gaap:NoncontrollingInterestMember 2025-03-31 0001392694 2025-03-31 0001392694 us-gaap:CommonStockMember 2023-12-31 0001392694 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001392694 us-gaap:RetainedEarningsMember 2023-12-31 0001392694 us-gaap:TreasuryStockCommonMember 2023-12-31 0001392694 us-gaap:NoncontrollingInterestMember 2023-12-31 0001392694 2023-12-31 0001392694 us-gaap:CommonStockMember 2024-03-31 0001392694 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001392694 us-gaap:RetainedEarningsMember 2024-03-31 0001392694 us-gaap:TreasuryStockCommonMember 2024-03-31 0001392694 us-gaap:NoncontrollingInterestMember 2024-03-31 0001392694 2024-03-31 0001392694 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001392694 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001392694 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001392694 us-gaap:TreasuryStockCommonMember 2025-01-01 2025-03-31 0001392694 us-gaap:NoncontrollingInterestMember 2025-01-01 2025-03-31 0001392694 2025-01-01 2025-03-31 0001392694 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0001392694 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0001392694 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0001392694 us-gaap:TreasuryStockCommonMember 2025-04-01 2025-06-30 0001392694 us-gaap:NoncontrollingInterestMember 2025-04-01 2025-06-30 0001392694 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001392694 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001392694 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001392694 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-03-31 0001392694 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-03-31 0001392694 2024-01-01 2024-03-31 0001392694 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001392694 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001392694 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001392694 us-gaap:TreasuryStockCommonMember 2024-04-01 2024-06-30 0001392694 us-gaap:NoncontrollingInterestMember 2024-04-01 2024-06-30 0001392694 us-gaap:CommonStockMember 2025-06-30 0001392694 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001392694 us-gaap:RetainedEarningsMember 2025-06-30 0001392694 us-gaap:TreasuryStockCommonMember 2025-06-30 0001392694 us-gaap:NoncontrollingInterestMember 2025-06-30 0001392694 us-gaap:CommonStockMember 2024-06-30 0001392694 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001392694 us-gaap:RetainedEarningsMember 2024-06-30 0001392694 us-gaap:TreasuryStockCommonMember 2024-06-30 0001392694 us-gaap:NoncontrollingInterestMember 2024-06-30 0001392694 2024-06-30 0001392694 SURG:SurgePaysIncMember SURG:ActiveEntitiesMember 2025-01-01 2025-06-30 0001392694 SURG:SurgeBlockchainLLCMember SURG:ActiveEntitiesMember 2025-01-01 2025-06-30 0001392694 SURG:EcsPrepaidLlcMember SURG:ActiveEntitiesMember 2025-01-01 2025-06-30 0001392694 SURG:TorchWirelessMember SURG:ActiveEntitiesMember 2025-01-01 2025-06-30 0001392694 SURG:SurgePaysFintechIncMember SURG:ActiveEntitiesMember 2025-01-01 2025-06-30 0001392694 SURG:SurgephoneWirelessLLCMember SURG:ActiveEntitiesMember 2025-01-01 2025-06-30 0001392694 SURG:ElectronicCheckServicesIncMember SURG:InActiveEntitiesMember 2025-01-01 2025-06-30 0001392694 SURG:CentralStatesLegalServicesIncMember SURG:InActiveEntitiesMember 2025-01-01 2025-06-30 0001392694 SURG:KsixLLCMember SURG:InActiveEntitiesMember 2025-01-01 2025-06-30 0001392694 SURG:DigitizeIQLLCMember SURG:InActiveEntitiesMember 2025-01-01 2025-06-30 0001392694 SURG:KsixMediaIncMember SURG:InActiveEntitiesMember 2025-01-01 2025-06-30 0001392694 SURG:SurgePaymentsLLCMember SURG:InActiveEntitiesMember 2025-01-01 2025-06-30 0001392694 SURG:LogicsIQIncMember SURG:ActiveEntitiesMember 2025-01-01 2025-06-30 0001392694 SURG:InjurySurveyLLCMember SURG:ActiveEntitiesMember 2025-01-01 2025-06-30 0001392694 SURG:ClearLineMobileIncMember 2024-01-05 0001392694 SURG:SigningMember 2024-01-05 2024-01-05 0001392694 SURG:ClosingMember 2024-01-05 2024-01-05 0001392694 SURG:NinetyDaysFromClosingMember 2024-01-05 2024-01-05 0001392694 SURG:HundredAndEightyDaysFromClosingMember 2024-01-05 2024-01-05 0001392694 2024-01-01 2024-12-31 0001392694 SURG:TrueWirelessIncMember 2021-05-07 0001392694 SURG:TrueWirelessIncMember 2021-05-07 2021-05-07 0001392694 2023-07-12 0001392694 us-gaap:CustomerConcentrationRiskMember SURG:SurgePhoneAndTorchWirelessMember us-gaap:RevenueFromContractWithCustomerMember 2025-01-01 2025-06-30 0001392694 us-gaap:CustomerConcentrationRiskMember SURG:SurgePhoneAndTorchWirelessMember us-gaap:RevenueFromContractWithCustomerMember 2024-01-01 2024-06-30 0001392694 us-gaap:CustomerConcentrationRiskMember SURG:FederalCommunicationsCommissionMember us-gaap:SalesRevenueNetMember 2025-01-01 2025-06-30 0001392694 us-gaap:CustomerConcentrationRiskMember SURG:FederalCommunicationsCommissionMember us-gaap:AccountsReceivableMember 2025-01-01 2025-06-30 0001392694 us-gaap:CustomerConcentrationRiskMember SURG:FederalCommunicationsCommissionMember us-gaap:AccountsReceivableMember 2024-01-01 2024-12-31 0001392694 2025-01-31 0001392694 us-gaap:GeneralAndAdministrativeExpenseMember 2025-04-01 2025-06-30 0001392694 us-gaap:GeneralAndAdministrativeExpenseMember 2025-01-01 2025-06-30 0001392694 us-gaap:GeneralAndAdministrativeExpenseMember 2024-04-01 2024-06-30 0001392694 us-gaap:GeneralAndAdministrativeExpenseMember 2024-01-01 2024-06-30 0001392694 SURG:CenterComGlobalMember 2019-01-17 0001392694 us-gaap:NotesReceivableMember 2025-06-30 0001392694 SURG:MobileVirtualNetworkOperatorsMember 2025-01-01 2025-06-30 0001392694 SURG:MobileVirtualNetworkOperatorsMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2025-01-01 2025-06-30 0001392694 SURG:MobileVirtualNetworkOperatorsMember 2024-01-01 2024-06-30 0001392694 SURG:MobileVirtualNetworkOperatorsMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2024-01-01 2024-06-30 0001392694 SURG:PointOfSaleAndPrepaidServicesMember 2025-01-01 2025-06-30 0001392694 SURG:PointOfSaleAndPrepaidServicesMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2025-01-01 2025-06-30 0001392694 SURG:PointOfSaleAndPrepaidServicesMember 2024-01-01 2024-06-30 0001392694 SURG:PointOfSaleAndPrepaidServicesMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2024-01-01 2024-06-30 0001392694 SURG:OtherCorporateOverheadMember 2025-01-01 2025-06-30 0001392694 SURG:OtherCorporateOverheadMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2025-01-01 2025-06-30 0001392694 SURG:OtherCorporateOverheadMember 2024-01-01 2024-06-30 0001392694 SURG:OtherCorporateOverheadMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2024-01-01 2024-06-30 0001392694 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2025-01-01 2025-06-30 0001392694 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2024-01-01 2024-06-30 0001392694 us-gaap:WarrantMember 2025-01-01 2025-06-30 0001392694 us-gaap:WarrantMember 2024-01-01 2024-06-30 0001392694 us-gaap:EmployeeStockOptionMember 2025-01-01 2025-06-30 0001392694 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-06-30 0001392694 SURG:CarddawgInvestmentsIncMember 2025-01-01 2025-06-30 0001392694 SURG:CarddawgInvestmentsIncMember 2024-01-01 2024-06-30 0001392694 us-gaap:ComputerEquipmentMember 2025-06-30 0001392694 us-gaap:ComputerEquipmentMember 2024-12-31 0001392694 us-gaap:ComputerEquipmentMember srt:MinimumMember 2025-06-30 0001392694 us-gaap:ComputerEquipmentMember srt:MaximumMember 2025-06-30 0001392694 us-gaap:LeaseholdImprovementsMember 2025-06-30 0001392694 us-gaap:LeaseholdImprovementsMember 2024-12-31 0001392694 us-gaap:FurnitureAndFixturesMember 2025-06-30 0001392694 us-gaap:FurnitureAndFixturesMember 2024-12-31 0001392694 us-gaap:FurnitureAndFixturesMember srt:MinimumMember 2025-06-30 0001392694 us-gaap:FurnitureAndFixturesMember srt:MaximumMember 2025-06-30 0001392694 us-gaap:ComputerSoftwareIntangibleAssetMember 2025-06-30 0001392694 us-gaap:ComputerSoftwareIntangibleAssetMember 2024-12-31 0001392694 us-gaap:TradeNamesMember 2025-06-30 0001392694 us-gaap:TradeNamesMember 2024-12-31 0001392694 SURG:ECSMembershipAgreementMember 2025-06-30 0001392694 SURG:ECSMembershipAgreementMember 2024-12-31 0001392694 us-gaap:NoncompeteAgreementsMember 2025-06-30 0001392694 us-gaap:NoncompeteAgreementsMember 2024-12-31 0001392694 us-gaap:CustomerRelationshipsMember 2025-06-30 0001392694 us-gaap:CustomerRelationshipsMember 2024-12-31 0001392694 srt:MinimumMember 2020-01-01 2020-12-31 0001392694 srt:MaximumMember 2020-01-01 2020-12-31 0001392694 SURG:KevinBrianCoxMember srt:ManagementMember 2024-03-12 0001392694 SURG:KevinBrianCoxMember srt:ManagementMember 2024-03-12 2024-03-12 0001392694 2025-05-12 2025-05-12 0001392694 2025-05-12 0001392694 2025-05-13 2025-05-13 0001392694 2025-05-13 0001392694 SURG:EconomicInjuryDisasterLoanMember 2025-01-01 2025-06-30 0001392694 us-gaap:RelatedPartyMember 2025-01-01 2025-06-30 0001392694 SURG:EconomicInjuryDisasterLoanOneMember 2025-01-01 2025-06-30 0001392694 SURG:EconomicInjuryDisasterLoanMember 2025-06-30 0001392694 SURG:EconomicInjuryDisasterLoanOneMember 2025-06-30 0001392694 SURG:EconomicInjuryDisasterLoanMember 2023-12-31 0001392694 SURG:EconomicInjuryDisasterLoanOneMember 2023-12-31 0001392694 SURG:EconomicInjuryDisasterLoanMember 2024-01-01 2024-12-31 0001392694 SURG:EconomicInjuryDisasterLoanOneMember 2024-01-01 2024-12-31 0001392694 SURG:EconomicInjuryDisasterLoanMember 2024-12-31 0001392694 SURG:EconomicInjuryDisasterLoanOneMember 2024-12-31 0001392694 SURG:KevinBrianCoxMember srt:ChiefExecutiveOfficerMember 2023-12-31 0001392694 SURG:KevinBrianCoxMember srt:ManagementMember 2023-12-31 0001392694 us-gaap:RelatedPartyMember 2023-12-31 0001392694 SURG:KevinBrianCoxMember srt:ChiefExecutiveOfficerMember 2024-01-01 2024-12-31 0001392694 SURG:KevinBrianCoxMember srt:ManagementMember 2024-01-01 2024-12-31 0001392694 us-gaap:RelatedPartyMember 2024-01-01 2024-12-31 0001392694 SURG:KevinBrianCoxMember srt:ChiefExecutiveOfficerMember 2024-12-31 0001392694 SURG:KevinBrianCoxMember srt:ManagementMember 2024-12-31 0001392694 SURG:KevinBrianCoxMember srt:ChiefExecutiveOfficerMember 2025-01-01 2025-06-30 0001392694 SURG:KevinBrianCoxMember srt:ManagementMember 2025-01-01 2025-06-30 0001392694 SURG:KevinBrianCoxMember srt:ChiefExecutiveOfficerMember 2025-06-30 0001392694 SURG:KevinBrianCoxMember srt:ManagementMember 2025-06-30 0001392694 SURG:NotesPayableOneMember us-gaap:RelatedPartyMember 2025-01-01 2025-06-30 0001392694 SURG:NotesPayableOneMember us-gaap:RelatedPartyMember 2025-06-30 0001392694 us-gaap:MeasurementInputExpectedTermMember 2025-06-30 0001392694 us-gaap:MeasurementInputPriceVolatilityMember 2025-06-30 0001392694 us-gaap:MeasurementInputExpectedDividendRateMember 2025-06-30 0001392694 us-gaap:MeasurementInputRiskFreeInterestRateMember 2025-06-30 0001392694 us-gaap:ConvertibleNotesPayableMember 2024-12-31 0001392694 us-gaap:ConvertibleNotesPayableMember 2025-01-01 2025-06-30 0001392694 us-gaap:ConvertibleNotesPayableMember 2025-06-30 0001392694 SURG:NotesPayableOneMember 2025-01-01 2025-06-30 0001392694 SURG:NotesPayableRelatedPartiesMember 2025-06-30 0001392694 SURG:NotesPayableSBAGovernmentMember 2025-06-30 0001392694 us-gaap:ConvertibleDebtMember 2025-06-30 0001392694 SURG:ClearLineMobileIncMember 2025-06-30 0001392694 2024-10-01 0001392694 2024-10-01 2024-10-01 0001392694 SURG:YearOneMember srt:ChiefFinancialOfficerMember 2023-11-01 2023-11-30 0001392694 SURG:YearTwoMember srt:ChiefFinancialOfficerMember 2023-11-01 2023-11-30 0001392694 SURG:YearThreeMember srt:ChiefFinancialOfficerMember 2023-11-01 2023-11-30 0001392694 srt:ChiefFinancialOfficerMember us-gaap:RestrictedStockMember 2023-11-10 0001392694 srt:ChiefFinancialOfficerMember us-gaap:RestrictedStockMember 2023-11-10 2023-11-10 0001392694 SURG:JulyTwoThousandTwentyFourDecemberTwoThousandTwentyFourMember srt:ChiefFinancialOfficerMember us-gaap:RestrictedStockMember 2023-11-10 0001392694 SURG:JanuaryTwoThousandTwentyFiveJuneTwoThousandTwentyFiveMember srt:ChiefFinancialOfficerMember us-gaap:RestrictedStockMember 2023-11-10 0001392694 SURG:JulyTwoThousandTwentyFiveDecemberTwoThousandTwentyFiveMember srt:ChiefFinancialOfficerMember us-gaap:RestrictedStockMember 2023-11-10 0001392694 srt:ChiefFinancialOfficerMember us-gaap:VehiclesMember 2023-11-10 2023-11-10 0001392694 srt:ChiefFinancialOfficerMember us-gaap:HomeBuildingMember 2023-11-10 2023-11-10 0001392694 srt:ChiefExecutiveOfficerMember 2023-12-01 2023-12-31 0001392694 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockMember 2024-03-01 0001392694 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockMember 2024-06-01 0001392694 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockMember 2024-07-01 0001392694 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockMember 2024-12-31 0001392694 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockMember 2024-01-01 2024-12-31 0001392694 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockMember 2025-06-26 0001392694 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockMember us-gaap:SubsequentEventMember 2026-06-01 0001392694 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockMember us-gaap:SubsequentEventMember 2027-06-01 0001392694 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockMember us-gaap:SubsequentEventMember 2028-06-01 0001392694 srt:ChiefExecutiveOfficerMember SURG:AnnualRevenueGoalsMember SURG:RestrictedStockOneMember 2023-12-01 2023-12-31 0001392694 srt:ChiefExecutiveOfficerMember SURG:AnnualRevenueGoalsMember SURG:RestrictedStockTwoMember 2023-12-01 2023-12-31 0001392694 srt:ChiefExecutiveOfficerMember SURG:AnnualRevenueGoalsMember SURG:RestrictedStockTwoMember 2025-01-01 2025-06-30 0001392694 srt:ChiefExecutiveOfficerMember SURG:AnnualRevenueGoalsMember SURG:RestrictedStockThreeMember 2023-12-01 2023-12-31 0001392694 srt:ChiefExecutiveOfficerMember SURG:AnnualRevenueGoalsMember SURG:RestrictedStockFourMember 2023-12-01 2023-12-31 0001392694 srt:ChiefExecutiveOfficerMember SURG:AnnualRevenueGoalsMember SURG:EachAdditionalRestrictedStockMember 2023-12-01 2023-12-31 0001392694 srt:ChiefExecutiveOfficerMember SURG:AnnualEBITDAGoalsMember SURG:RestrictedStockOneMember 2023-12-01 2023-12-31 0001392694 srt:ChiefExecutiveOfficerMember SURG:AnnualEBITDAGoalsMember SURG:RestrictedStockTwoMember 2023-12-01 2023-12-31 0001392694 srt:ChiefExecutiveOfficerMember SURG:AnnualEBITDAGoalsMember SURG:EachAdditionalRestrictedStockMember 2023-12-01 2023-12-31 0001392694 srt:ChiefExecutiveOfficerMember SURG:MarketCapitalizationGoalsMember SURG:RestrictedStockOneMember 2023-12-01 2023-12-31 0001392694 srt:ChiefExecutiveOfficerMember SURG:MarketCapitalizationGoalsMember SURG:RestrictedStockTwoMember 2023-12-01 2023-12-31 0001392694 srt:ChiefExecutiveOfficerMember SURG:MarketCapitalizationGoalsMember SURG:RestrictedStockThreeMember 2023-12-01 2023-12-31 0001392694 srt:ChiefExecutiveOfficerMember SURG:MarketCapitalizationGoalsMember SURG:RestrictedStockFourMember 2023-12-01 2023-12-31 0001392694 srt:ChiefExecutiveOfficerMember SURG:MarketCapitalizationGoalsMember SURG:EachAdditionalRestrictedStockMember 2023-12-01 2023-12-31 0001392694 srt:ChiefExecutiveOfficerMember us-gaap:VehiclesMember 2023-12-01 2023-12-31 0001392694 srt:ChiefExecutiveOfficerMember us-gaap:HomeBuildingMember 2023-01-01 2023-12-31 0001392694 SURG:BlueSkiesConnectionsLLCMember 2023-08-08 2023-08-08 0001392694 SURG:BlueSkiesConnectionsLLCMember 2023-08-08 0001392694 SURG:SeriesAConvertiblePreferredStocksMember 2025-06-30 0001392694 SURG:SeriesAConvertiblePreferredStocksMember 2025-01-01 2025-06-30 0001392694 SURG:SeriesCConvertiblePreferredStocksMember 2025-06-30 0001392694 SURG:SeriesCConvertiblePreferredStocksMember 2025-01-01 2025-06-30 0001392694 us-gaap:CommonStockMember SURG:TwoThousandAndTwentyTwoPlanMember 2023-03-01 2023-03-31 0001392694 SURG:TwoThousandAndTwentyTwoPlanMember 2023-01-01 2023-12-31 0001392694 SURG:TwoThousandAndTwentyTwoPlanMember 2023-12-31 0001392694 SURG:TwoThousandAndTwentyTwoPlanMember 2024-01-01 2024-12-31 0001392694 SURG:TwoThousandAndTwentyTwoPlanMember 2024-12-31 0001392694 us-gaap:TreasuryStockCommonMember 2025-01-01 2025-06-30 0001392694 us-gaap:WarrantMember 2024-12-31 0001392694 us-gaap:WarrantMember 2024-01-01 2024-12-31 0001392694 srt:MinimumMember 2024-12-31 0001392694 srt:MaximumMember 2024-12-31 0001392694 2024-07-31 0001392694 2024-07-01 2024-07-31 0001392694 srt:ChiefFinancialOfficerMember 2023-01-01 2023-12-31 0001392694 srt:ChiefFinancialOfficerMember 2023-12-31 0001392694 srt:ChiefFinancialOfficerMember 2025-04-01 2025-06-30 0001392694 srt:ChiefFinancialOfficerMember 2024-04-01 2024-06-30 0001392694 srt:ChiefFinancialOfficerMember 2025-01-01 2025-06-30 0001392694 srt:ChiefFinancialOfficerMember 2024-01-01 2024-06-30 0001392694 srt:BoardOfDirectorsChairmanMember 2025-01-01 2025-06-30 0001392694 srt:BoardOfDirectorsChairmanMember 2025-06-30 0001392694 srt:BoardOfDirectorsChairmanMember 2024-01-01 2024-12-31 0001392694 srt:BoardOfDirectorsChairmanMember 2024-12-31 0001392694 srt:BoardOfDirectorsChairmanMember 2025-04-01 2025-06-30 0001392694 srt:BoardOfDirectorsChairmanMember 2024-04-01 2024-06-30 0001392694 srt:BoardOfDirectorsChairmanMember 2024-01-01 2024-06-30 0001392694 srt:ChiefExecutiveOfficerMember 2024-01-01 2024-12-31 0001392694 srt:ChiefExecutiveOfficerMember 2024-12-31 0001392694 srt:ChiefExecutiveOfficerMember 2025-04-01 2025-06-30 0001392694 srt:ChiefExecutiveOfficerMember 2024-04-01 2024-06-30 0001392694 srt:ChiefExecutiveOfficerMember 2025-01-01 2025-06-30 0001392694 srt:ChiefExecutiveOfficerMember 2024-01-01 2024-06-30 0001392694 srt:DirectorMember 2024-01-01 2024-12-31 0001392694 srt:DirectorMember 2024-12-31 0001392694 srt:DirectorMember 2024-01-01 2024-03-31 0001392694 srt:DirectorMember 2024-01-01 2024-06-30 0001392694 srt:ChiefFinancialOfficerMember 2024-01-01 2024-12-31 0001392694 us-gaap:EmployeeStockMember 2024-01-01 2024-12-31 0001392694 SURG:EmployeeMember 2024-01-01 2024-12-31 0001392694 SURG:OfficersStockMember 2024-01-01 2024-12-31 0001392694 us-gaap:EmployeeStockMember 2024-12-31 0001392694 srt:ChiefExecutiveOfficerMember us-gaap:CommonStockMember 2023-12-31 0001392694 srt:ChiefFinancialOfficerMember us-gaap:CommonStockMember 2023-12-31 0001392694 us-gaap:CommonStockMember SURG:DirectorsMember 2023-12-31 0001392694 us-gaap:CommonStockMember SURG:DirectorsofHumanResourcesLegalMember 2023-12-31 0001392694 srt:ChiefExecutiveOfficerMember us-gaap:CommonStockMember 2024-01-01 2024-12-31 0001392694 srt:ChiefFinancialOfficerMember us-gaap:CommonStockMember 2024-01-01 2024-12-31 0001392694 us-gaap:CommonStockMember SURG:DirectorsMember 2024-01-01 2024-12-31 0001392694 us-gaap:CommonStockMember SURG:DirectorsofHumanResourcesLegalMember 2024-01-01 2024-12-31 0001392694 us-gaap:CommonStockMember 2024-01-01 2024-12-31 0001392694 srt:ChiefExecutiveOfficerMember us-gaap:CommonStockMember 2024-12-31 0001392694 srt:ChiefFinancialOfficerMember us-gaap:CommonStockMember 2024-12-31 0001392694 us-gaap:CommonStockMember SURG:DirectorsMember 2024-12-31 0001392694 us-gaap:CommonStockMember SURG:DirectorsofHumanResourcesLegalMember 2024-12-31 0001392694 srt:ChiefExecutiveOfficerMember us-gaap:CommonStockMember 2025-01-01 2025-06-30 0001392694 srt:ChiefFinancialOfficerMember us-gaap:CommonStockMember 2025-01-01 2025-06-30 0001392694 us-gaap:CommonStockMember SURG:DirectorsMember 2025-01-01 2025-06-30 0001392694 us-gaap:CommonStockMember SURG:DirectorsofHumanResourcesLegalMember 2025-01-01 2025-06-30 0001392694 us-gaap:CommonStockMember 2025-01-01 2025-06-30 0001392694 srt:ChiefExecutiveOfficerMember us-gaap:CommonStockMember 2025-06-30 0001392694 srt:ChiefFinancialOfficerMember us-gaap:CommonStockMember 2025-06-30 0001392694 us-gaap:CommonStockMember SURG:DirectorsMember 2025-06-30 0001392694 us-gaap:CommonStockMember SURG:DirectorsofHumanResourcesLegalMember 2025-06-30 0001392694 2023-01-01 2023-12-31 0001392694 SURG:CEOandCFOandEmployeesMember 2025-04-01 2025-06-30 0001392694 SURG:CEOandCFOandEmployeesMember 2024-04-01 2024-06-30 0001392694 SURG:CEOandCFOandEmployeesMember 2025-01-01 2025-06-30 0001392694 SURG:CEOandCFOandEmployeesMember 2024-01-01 2024-06-30 0001392694 SURG:MobileVirtualNetworkOperatorMember 2025-04-01 2025-06-30 0001392694 SURG:MobileVirtualNetworkOperatorMember 2024-04-01 2024-06-30 0001392694 SURG:MobileVirtualNetworkOperatorMember 2025-01-01 2025-06-30 0001392694 SURG:MobileVirtualNetworkOperatorMember 2024-01-01 2024-06-30 0001392694 SURG:PointOfSaleAndPrepaidServicesMember 2025-04-01 2025-06-30 0001392694 SURG:PointOfSaleAndPrepaidServicesMember 2024-04-01 2024-06-30 0001392694 SURG:PointOfSaleAndPrepaidServicesMember 2025-01-01 2025-06-30 0001392694 SURG:PointOfSaleAndPrepaidServicesMember 2024-01-01 2024-06-30 0001392694 SURG:OtherCorporateOverheadMember 2025-04-01 2025-06-30 0001392694 SURG:OtherCorporateOverheadMember 2024-04-01 2024-06-30 0001392694 SURG:OtherCorporateOverheadMember 2025-01-01 2025-06-30 0001392694 SURG:OtherCorporateOverheadMember 2024-01-01 2024-06-30 0001392694 SURG:MobileVirtualNetworkOperatorMember 2025-06-30 0001392694 SURG:MobileVirtualNetworkOperatorMember 2024-12-31 0001392694 SURG:PointOfSaleAndPrepaidServicesMember 2025-06-30 0001392694 SURG:PointOfSaleAndPrepaidServicesMember 2024-12-31 0001392694 SURG:OtherCorporateOverheadMember 2025-06-30 0001392694 SURG:OtherCorporateOverheadMember 2024-12-31 0001392694 srt:MaximumMember us-gaap:SubsequentEventMember SURG:AtTheMarketOfferingAgreementMember 2025-08-01 2025-08-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure utr:sqft

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2025

 

or

 

 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ________________ to ________________

 

Commission file number 001-40992

 

SURGEPAYS, INC.

(Exact name of registrant as specified in its charter)

 

Nevada   98-0550352

(State or other jurisdiction of

incorporation or organization)

 

(I. R. S. Employer

Identification No.)

 

3124 Brother Blvd, Suite 104    
Bartlett TN   38133
(Address of principal executive offices)   (Zip Code)

 

901-302-9587

(Registrant’s telephone number, including area code)

 

Not applicable

(Former name, former address, and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock   SURG  

The Nasdaq Stock Market LLC

(Nasdaq Capital Market)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer ☒ Smaller reporting company 
  Emerging growth company 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided to Section 7(a)(2)(B) of the Securities Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in rule 12b-2 of the Exchange Act). Yes ☐ No 

 

The number of shares of the registrant’s common stock outstanding as of August 13, 2025 was 20,431,549 shares.

 

 

 

 
 

 

SurgePays, Inc. and Subsidiaries

 

    Page(s)
     
Consolidated Balance Sheets   3
     
Consolidated Statements of Operations   4
     
Consolidated Statements of Changes in Stockholders’ Equity   5 - 6
     
Consolidated Statements of Cash Flows   7
     
Notes to Consolidated Financial Statements   8 - 59

 

2

 

 

SurgePays, Inc. and Subsidiaries

Consolidated Balance Sheets

 

   June 30, 2025   December 31, 2024 
   (Unaudited)     
Assets        
         
Current Assets          
Cash and cash equivalents  $4,404,449   $11,790,389 
Restricted cash - held in escrow   -    1,000,000 
Accounts receivable - net   2,680,713    3,000,209 
Inventory   2,410,817    1,781,365 
Prepaids and other   198,403    298,360 
Total Current Assets   9,694,382    17,870,323 
           
Property and equipment - net   457,195    591,088 
           
Other Assets          
Note receivable   176,851    176,851 
Intangibles - net   1,145,756    1,472,962 
Goodwill   3,300,000    3,300,000 
Operating lease - right of use asset - net   441,225    564,781 
Total Other Assets   5,063,832    5,514,594 
           
Total Assets  $15,215,409   $23,976,005 
           
Liabilities and Stockholders’ Equity          
           
Current Liabilities          
Accounts payable and accrued expenses  $5,108,402   $3,929,195 
Accounts payable and accrued expenses - related party   -    192,845 
Operating lease liability   248,069    248,069 
Note payable - related party   1,915,331    1,689,367 
Convertible note payable - net   1,430,267    - 
Total Current Liabilities   8,702,069    6,059,476 
           
Long Term Liabilities          
Note payable - related party   955,905    1,866,288 
Notes payable - SBA government   463,884    469,396 
Operating lease liability   198,180    319,232 
Convertible note payable - net   4,833,979    - 
Total Long Term Liabilities   6,451,948    2,654,916 
           
Total Liabilities   15,154,017    8,714,392 
           
Stockholders’ Equity          
Common stock, $0.001 par value, 500,000,000 shares authorized 20,431,549 and 20,431,549 shares issued and 19,735,596 and 20,068,929 shares outstanding, at June 30, 2025 and December 31, 2024, respectively   20,435    20,435 
Additional paid-in capital   77,360,756    76,842,878 
Treasury stock - at cost (695,953 and 362,620 shares, respectively)   (1,631,966)   (631,967)
Accumulated deficit   (75,633,109)   (60,915,427)
Stockholders’ equity   116,116    15,315,919 
Non-controlling interest   (54,724)   (54,306)
Total Stockholders’ Equity   61,392    15,261,613 
           
Total Liabilities and Stockholders’ Equity  $15,215,409   $23,976,005 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

3

 

 

SurgePays, Inc. and Subsidiaries

Consolidated Statements of Operations

(Unaudited)

 

   2025   2024   2025   2024 
   For the Three Months Ended June 30,   For the Six Months Ended June 30, 
   2025   2024   2025   2024 
                 
Revenues  $11,518,166   $15,085,699   $22,095,596   $46,514,834 
                     
Costs and expenses                    
Cost of revenues   14,172,832    18,528,774    27,692,607    41,775,243 
General and administrative expenses   4,155,843    7,432,978    8,793,401    13,863,783 
Total costs and expenses   18,328,675    25,961,752    36,486,008    55,639,026 
                     
Loss from operations   (6,810,509)   (10,876,053)   (14,390,412)   (9,124,192)
                     
Other income (expense)                    
Interest expense   (212,419)   (116,722)   (331,853)   (249,305)
Interest income   7,008    -    64,267    - 
Other income        636,868    6,785    636,868 
Gain on investment in CenterCom   -    17,711    -    33,864 
Amortization of debt discount   (66,887)   -    (66,887)   - 
Total other income (expense) - net   (272,298)   537,857    (327,688)   421,427 
                     
Net loss before provision for income taxes   (7,082,807)   (10,338,196)   (14,718,100)   (8,702,765)
                     
Provision for income tax benefit (expense)   -    (2,547,000)   -    (2,970,000)
                     
Net loss including non-controlling interest   (7,082,807)   (12,885,196)   (14,718,100)   (11,672,765)
                     
Non-controlling interest   (209)   (19,431)   (418)   (31,595)
                     
Net loss available to common stockholders  $(7,082,598)  $(12,865,765)  $(14,717,682)  $(11,641,170)
                     
Earnings per share - attributable to common stockholders                    
Basic  $(0.36)  $(0.66)  $(0.74)  $(0.63)
Diluted  $(0.36)  $(0.66)  $(0.74)  $(0.63)
                     
Weighted average number of shares outstanding - attributable to common stockholders                    
Basic   19,889,442    19,431,549    19,978,690    18,562,416 
Diluted   19,889,442    19,431,549    19,978,690    18,562,416 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

4

 

 

SurgePays, Inc. and Subsidiaries

Consolidated Statements of Changes in Stockholders’ Equity

(Unaudited)

 

           Additional                   Total 
   Common Stock   Paid-in   Accumulated   Treasury Stock   Non-Controlling   Stockholders’ 
   Shares   Amount   Capital   Deficit   Shares   Amount   Interest   Equity 
                                 
December 31, 2024   20,431,549   $20,435   $76,842,878   $(60,915,427)   362,620   $(631,967)  $               (54,306)  $    15,261,613 
                                         
Recognition of stock based compensation - unvested shares - related parties   -    -    155,119    -    -    -    -    155,119 
                                         
Non-controlling interest   -    -    -    -    -    -    (209)   (209)
                                         
Net loss   -    -    -    (7,635,084)   -    -    -    (7,635,084)
                                         
March 31, 2025   20,431,549    20,435    76,997,997    (68,550,511)   362,620    (631,967)   (54,515)   7,781,439 
                                         
Recognition of stock based compensation - unvested shares - related parties   -    -    155,119    -    -    -    -    155,119 
                                         
Debt discount - convertible note payable - warrants issued   -    -    207,640    -    -    -    -    207,640 
                                         
Treasury stock reacquired in connection with convertible debt financing   -    -    -    -    333,333    (999,999)   -    (999,999)
                                         
Non-controlling interest   -    -    -    -    -    -    (209)   (209)
                                         
Net loss   -    -    -    (7,082,598)   -    -    -    (7,082,598)
                                         
June 30, 2025   20,431,549    20,435    77,360,756    (75,633,109)   695,953    (1,631,966)   (54,724)   61,392 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

5

 

 

SurgePays, Inc. and Subsidiaries

Consolidated Statements of Changes in Stockholders’ Equity

(Unaudited)

 

           Additional           Total 
   Common Stock   Paid-in   Accumulated   Non-Controlling   Stockholders’ 
   Shares   Amount   Capital   Deficit   Interest   Equity 
                         
December 31, 2023   14,403,261   $14,404   $43,421,019   $(15,186,203) - $               154,244   $    28,403,464 
                               
Stock issued for cash   3,080,356    3,081    17,246,913    -    -    17,249,994 
                               
Cash paid as direct offering costs   -    -    (1,395,000)   -    -    (1,395,000)
                               
Exercise of warrants - cash   1,860,308    1,861    8,797,396    -    -    8,799,257 
                               
Exercise of warrants - cashless   40,238    41    (41)   -    -    - 
                               
Stock issued for services   47,386    48    411,692    -    -    411,740 
                               
Recognition of stock based compensation - unvested shares - related parties   -    -    1,497,417    -    -    1,497,417 
                               
Recognition of stock-based compensation - related party   -    -    6,196    -    -    6,196 
                               
Non-controlling interest   -    -    -    -    (12,164)   (12,164)
                               
Net income   -    -    -    1,224,595  -  -    1,224,595 
                               
March 31, 2024   19,431,549    19,435    69,985,592    (13,961,608) -  142,080    56,185,499 
                               
Recognition of stock based compensation - unvested shares - related parties   -    -    2,981,577    -    -    2,981,577 
                               
Non-controlling interest   -    -    -    -    (19,431)   (19,431)
                               
Net loss   -    -    -    (12,865,765) -  -    (12,865,765)
                               
June 30, 2024   19,431,549   $19,435   $72,967,169   $(26,827,373) - $122,649   $46,281,880 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

6

 

 

SurgePays, Inc. and Subsidiaries

Consolidated Statements of Cash Flows

(Unaudited)

 

   2025   2024 
   For the Six Months Ended June 30, 
   2025   2024 
         
Operating activities          
Net loss - including non-controlling interest  $(14,718,100)  $(11,672,765)
Adjustments to reconcile net loss to net cash used in operations          
Depreciation and amortization   479,689    467,520 
Amortization of right-of-use assets   123,556    46,995 
Amortization of debt discount/debt issue costs   66,887    - 
Amortization of internal use software development costs   -    111,414 
Stock issued for services   -    411,740 
Recognition of stock based compensation - unvested shares - related parties   310,238    4,478,994 
Recognition of share based compensation - options - related party   -    6,196 
Interest expense adjustment - SBA loans   -    19,750 
Right-of-use asset lease payment adjustment true up   -    (97,346)
Gain on equity method investment - CenterCom   -    (33,864)
Changes in operating assets and liabilities          
(Increase) decrease in          
Accounts receivable   319,496    8,123,897 
Inventory   (629,452)   683,160 
Prepaids and other   99,957    (345,994)
Deferred income taxes - net   -    2,835,000 
Increase (decrease) in          
Accounts payable and accrued expenses   1,179,207    (4,641,563)
Accounts payable and accrued expenses - related party   (192,845)   (49,380)
Accrued income taxes payable   -    (470,000)
Deferred revenue   -    (20,000)
Operating lease liability   (121,052)   56,134 
Net cash used in operating activities   (13,082,419)   (90,112)
           
Investing activities          
Purchase of leasehold improvements   (18,590)   - 
Net cash used in investing activities   (18,590)   - 
           
Financing activities          
Proceeds from stock issued for cash   -    17,249,994 
Proceeds from exercise of common stock warrants   -    8,799,257 
Cash paid as direct offering costs - common stock   -    (1,395,000)
Proceeds from issuance of convertible note payable   6,000,000    - 
Cash paid as direct offering costs - convertible note payable   (595,000)   - 
Repayments of loans - related party   (684,419)   (746,104)
Repayments on notes payable - SBA government   (5,512)   (5,515)
Net cash provided by financing activities   4,715,069    23,902,632 
           
Net increase (decrease) in cash, cash equivalents and restricted cash   (8,385,940)   23,812,520 
           
Cash, cash equivalents and restricted cash - beginning of period   12,790,389    14,622,060 
           
Cash, cash equivalents and restricted cash - end of period  $4,404,449   $38,434,580 
           
Supplemental disclosure of cash flow information          
Cash paid for interest  $188,244  $259,765 
Cash paid for income tax  $-   $- 
           
Supplemental disclosure of non-cash investing and financing activities          
           
Reclassification of accrued interest - related party to note payable - related party  $-   $498,991 
Exercise of warrants - cashless  $-   $41 
Goodwill (ClearLine Mobile, Inc.)  $-   $2,500,000 
Right-of-use asset obtained in exchange for new operating lease liability  $-   $98,638 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

7

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

Note 1 - Organization and Nature of Operations

 

Organization and Nature of Operations

 

SurgePays, Inc. (“SurgePays,” “we,” or the “Company”) is a telecommunications and financial technology company focused on delivering wireless connectivity and point-of-sale solutions to underserved and value-conscious communities across the United States. The Company’s mission is to enhance access to essential digital services where people live, shop, and work.

 

We operate through three primary business segments: (1) our MVNO wireless brands, (2) our MVNE enablement platform (HERO), and (3) our point-of-sale (POS) and fintech services. These businesses are supported through subsidiaries including SurgePhone Wireless, LLC, SurgePays Fintech, Inc., ECS Prepaid, LLC, and Torch Wireless, LLC, among others.

 

The Company and its subsidiaries are organized as follows:

 

Company Name (Active)   Incorporation Date   State of Incorporation   Segment
SurgePays, Inc.   August 18, 2006   Nevada   Corporate Parent
Surge Blockchain, LLC   January 29, 2009   Nevada   Other Corporate Overhead
ECS Prepaid, LLC   June 9, 2009   Missouri   Point-of-Sale and Prepaid Services
Torch Wireless   January 29, 2019   Wyoming   Mobile Virtual Network Operators
SurgePays Fintech, Inc.   August 22, 2019   Nevada   Point-of-Sale and Prepaid Services
SurgePhone Wireless, LLC   August 29, 2019   Nevada   Mobile Virtual Network Operators

 

All of the following entities have nominal operations.

 

Company Name (Inactive)   Incorporation Date   State of Incorporation    
Electronic Check Services, Inc.   May 19, 1999   Missouri    
Central States Legal Services, Inc.   August 1, 2003   Missouri    
KSIX, LLC   September 14, 2011   Nevada    
DigitizeIQ, LLC   July 23, 2014   Illinois    
KSIX Media, Inc.   November 5, 2014   Nevada    
Surge Payments, LLC   December 17, 2018   Nevada    

LogicsIQ, Inc.   October 2, 2018   Nevada   Other Corporate Overhead
Injury Survey, LLC   July 28, 2020   Nevada   Other Corporate Overhead

 

See discussion below the discontinuation of the Company’s lead generation segment.

 

8

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

Discontinued Operations – LogicsIQ Segment

 

Management’s Decision

 

Effective December 31, 2024, the Company’s management elected to abandon its lead generation segment operations as part of a strategic reassessment of its business lines. This decision followed a review by the Chief Operating Decision Maker (“CODM”, which is our Chief Executive Officer), who had been regularly evaluating the segment’s financial performance and determined that its continued operation was no longer aligned with the Company’s long-term strategic objectives.

 

In accordance with ASC 205-20, Presentation of Financial Statements – Discontinued Operations, the Company assessed whether the abandonment met the criteria for classification as a discontinued operation. ASU 2014-08 provides that a discontinued operation must represent a strategic shift that has (or will have) a major effect on an entity’s operations and financial results. The Company determined that this threshold was not met for the following reasons:

 

Revenue and Asset Impact: The lead generation segment contributed 0% of total consolidated revenue and less than 1% of total assets, making it an immaterial component of the Company’s overall business. The exit does not result in a significant change to revenue streams, total assets, or capital allocation.
Lack of Operational Significance: The segment was not integral to the Company’s primary business strategy and had been operating with minimal investment in technology, personnel, and infrastructure.
No Industry or Geographic Exit: The Company is not exiting a major product line, customer segment, or geographical region. All other segments remain unaffected by this decision, and the Company continues to operate in its primary markets with no material shift in business focus.
Strategic Realignment Rather Than Transformation: The abandonment reflects a refinement of operational priorities rather than a fundamental transformation of the Company’s core business model. The Company continues to focus on its core service offerings, which contribute the majority of revenue and drive long-term growth.

 

Based on these factors, the Company has concluded that the abandonment does not constitute a strategic shift that has or will have a major effect on its financial results or operations. As a result, the segment will not be presented as a discontinued operation in the financial statements.

 

9

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

Segment Reporting (ASC 280) Considerations

 

Under ASC 280, Segment Reporting, the lead generation segment was historically identified as a reportable segment, as the CODM regularly reviewed its financial performance separately from other segments. However, given its diminished financial impact and lack of long-term strategic significance, the Company has concluded that the segment no longer meets the quantitative or qualitative thresholds for separate segment reporting. Accordingly, financial data previously presented under the Lead Generation segment will be reclassified to “Other” in the segment disclosure included in Note 10 to the consolidated financial statements.

 

In line with the amendments introduced by ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, (adopted January 1, 2024), the Company has evaluated the impact of this change on its segment disclosures. The key considerations are as follows:

 

Significant Expense Disclosures: The Company has identified that the lead generation segment did not have any significant expenses that were regularly provided to the CODM and included in the reported measure of segment profit or loss. Therefore, no additional disclosures are required under the new guidance.
Other Segment Items: As the lead generation segment is being reclassified to “Other,” for its segment disclosure, the Company will disclose the composition of this category, including the nature and type of activities aggregated therein, as required by the updated standard.
Interim Reporting: The Company will ensure that all annual disclosures about reportable segments’ profit or loss and assets, as mandated by ASC 280 and the amendments from ASU 2023-07, are also provided in interim periods going forward.

 

Accounting and Financial Statement Impact

 

Since the lead generation segment is being abandoned rather than sold, it does not qualify as held for sale. The Company does not expect to recognize any material exit costs, impairment losses, or restructuring charges related to this decision. Any remaining assets and liabilities associated with the segment will be derecognized as appropriate in accordance with applicable accounting standards.

 

10

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

Future Business Operations

 

The lead generation segment did not have any workforce, customers, or existing contracts, and its abandonment will not result in any employee layoffs, customer transitions, or contract terminations. This decision reflects management’s focus on core business areas that offer higher growth potential and operational efficiency.

 

Basis of Presentation

 

The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial statements (“U.S. GAAP”) and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the United States Securities and Exchange Commission (“SEC”). Accordingly, they do not contain all information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements.

 

In the opinion of the Company’s management, the accompanying unaudited consolidated financial statements contain all of the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of June 30, 2025 and the results of operations and cash flows for the periods presented. The results of operations for the six months ended June 30, 2025 are not necessarily indicative of the operating results for the full fiscal year or any future period.

 

These unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on March 25, 2025.

 

Management acknowledges its responsibility for the preparation of the accompanying unaudited consolidated financial statements which reflect all adjustments, consisting of normal recurring adjustments, considered necessary in its opinion for a fair statement of its consolidated financial position and the consolidated results of its operations for the periods presented.

 

11

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

Liquidity and Management’s Plans

 

As reflected in the accompanying consolidated financial statements, for the six months ended June 30, 2025, the Company had:

 

Net loss available to common stockholders of $14,717,682; and
Net cash used in operations was $13,082,419

 

Additionally, at June 30, 2025, the Company had:

 

Accumulated deficit of $75,633,109
Stockholders’ equity of $61,392; and
Working capital of $992,313

 

We manage liquidity risk by reviewing, on an ongoing basis, our sources of liquidity and capital requirements. The Company has cash on hand of $4,404,449 at June 30, 2025.

 

The Company has historically incurred significant losses and has not demonstrated an ability to generate sufficient revenues from the sales of its products and services to achieve profitable operations.

 

There can be no assurance that profitable operations will be achieved and could be sustained on a continuing basis. In making this assessment we performed a comprehensive analysis of our current circumstances including: our financial position, our cash flows and cash usage forecasts for the twelve months ending June 30, 2026, and our current capital structure including equity-based instruments and our obligations and debts.

 

Effective February 7, 2024, the Affordable Connectivity Program (“ACP”) stopped accepting new applications and enrollments. The program ceased funding on June 1, 2024. See discussion below regarding revenue recognition.

 

The Company believes it lacks sufficient cash resources on hand to meet its current obligations for a period that is more than one year from the issuance date of these consolidated financial statements.

 

These factors create substantial doubt about the Company’s ability to continue as a going concern within the twelve month period subsequent to the date that these consolidated financial statements are issued. The consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. Accordingly, the consolidated financial statements have been prepared on a basis that assumes the Company will continue as a going concern and which contemplates the realization of assets and satisfaction of liabilities and commitments in the ordinary course of business.

 

Management’s strategic plans include the following:

 

Enhance market visibility and customer reach for SurgePays’ direct mobile virtual network operator (“MVNO”), linkup Mobile,
Diversify Lifeline revenue streams by expanding into California and other states,
Sustain platform growth to bolster baseline revenue; and
Investigate specialized marketing strategies and customer engagement initiatives through our Clearline product offering.

 

12

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

Note 2 - Summary of Significant Accounting Policies

 

Principles of Consolidation and Non-Controlling Interest

 

These unaudited consolidated financial statements have been prepared in accordance with U.S. GAAP and include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated.

 

For entities that are consolidated, but not 100% owned, a portion of the income or loss and corresponding equity is allocated to owners other than the Company. The aggregate of the income or loss and corresponding equity that is not owned by us is included in Non-controlling Interests in the consolidated financial statements.

 

Business Combinations and Asset Acquisitions

 

The Company accounts for acquisitions that qualify as business combinations by applying the acquisition method according to Accounting Standards Codification (“ASC”) 805, Business Combinations (“ASC 805”).

 

Transaction costs related to the acquisition of a business are expensed as incurred and excluded from the fair value of consideration transferred.

 

The identifiable assets acquired, liabilities assumed, and noncontrolling interests in an acquired entity are recognized and measured at their estimated fair values. The excess of the fair value of consideration transferred over the fair values of identifiable assets acquired, liabilities assumed, and noncontrolling interests in an acquired entity, net of the fair value of any previously held interest in the acquired entity, is recorded as goodwill. Such valuations require management to make significant estimates and assumptions.

 

Purchase price allocations may be preliminary, and, during the measurement period not to exceed one year from the date of acquisition, changes in assumptions and estimates that result in adjustments to the fair value of assets acquired and liabilities assumed are recorded in the period the adjustments are determined.

 

Significant judgments are used in determining fair values of assets acquired and liabilities assumed, as well as intangibles. Fair value and useful life determinations are based on, among other factors, estimates of future expected cash flows, and appropriate discount rates used in computing present values. These judgments may materially impact the estimates used in allocating acquisition date fair values to assets acquired and liabilities assumed, as well as the Company’s current and future operating results. Actual results may vary from these estimates which may result in adjustments to goodwill and acquisition date fair values of assets and liabilities during a measurement period or upon a final determination of asset and liability fair values, whichever occurs first. Adjustments to fair values of assets and liabilities made after the end of the measurement period are recorded within the Company’s earnings.

 

13

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

The Company evaluates acquisitions of assets and other similar transactions to assess whether the transaction should be accounted for as a business combination or asset acquisition by first applying a screen test to determine whether substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets. If so, the transaction is accounted for as an asset acquisition. If not, further determination is required as to whether the Company has acquired inputs and processes that can create outputs that would meet the definition of a business. When applying the screen test, significant judgment is required to determine whether an acquisition is a business combination or an acquisition of assets.

 

Accounting for asset acquisitions falls under the guidance of Topic 805, Business Combinations, specifically Subtopic 805-50. A cost accumulation model is used to determine an asset acquisition’s cost. Assets acquired are based on their cost, generally allocated to them on a relative fair value basis. Direct acquisition-related costs are included in the cost of the acquired assets.

 

The distinction between business combinations and asset acquisitions involves judgment, particularly when applying the screen test to determine the nature of the transaction. Incorrect judgments or changes in decisions in these areas could materially affect the determination of goodwill, the recognition and measurement of acquired assets and assumed liabilities, and, consequently, our financial position and results of operations.

 

Acquisition of ClearLine Mobile, Inc

 

On January 5, 2024, the Company closed a purchase agreement and acquired ClearLine Mobile, Inc’s. (“CLMI”) related software development in exchange for $2,500,000.

 

ClearLine is a proprietary software-as-a-service (SaaS) platform designed to deliver real-time, point-of-sale (POS) marketing and customer engagement for retail merchants. The platform integrates with POS terminals, touchscreen displays, digital signage, and mobile interfaces to enable centralized control of in-store promotions, customer acquisition tools, and loyalty program interactions.

 

ClearLine supports various engagement channels, including:

 

  Interactive screen prompts on payment terminals and kiosks;
  NFC smart tags and QR codes placed on signage, product packaging, and marketing materials;
  Receipt-based marketing messages, including personalized offers, loyalty information, and calls to action printed on or linked from digital and physical receipts.

 

Merchants utilize ClearLine to deploy customer engagement applications such as review generation, social media follows, SMS opt-ins, coupon distribution, and loyalty program enrollment. The platform includes a centralized content management system (CMS) for controlling campaign content, as well as analytics and reporting tools to measure performance by location, campaign, and engagement type.

 

ClearLine is fully integrated into the SurgePays software ecosystem, enhancing the capabilities of participating merchants to drive customer retention, increase average transaction value, and generate new revenue through in-store and post-transaction marketing.

 

Following the guidance of ASC 805, we performed the screen test to evaluate whether the acquired set is a business or a group of assets. The acquired group of assets included inputs and a substantive process that together significantly contributed to the ability to create outputs. At the time of purchase, CLMI had insignificant operations, however, the transaction was accounted for as a business combination in accordance with ASC 805-50.

 

14

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

Payments were paid as follows:

 

-$100,000 at signing,
-$800,000 at closing,
-$800,000 90 days from closing (April 2024)
-$800,000 180 days from closing (July 2024)

 

In connection with this business combination, the Company assumed a right-of-use operating lease and corresponding lease liability of $98,638 with a period of two (2) years remaining.

 

Additionally, the acquired technology/software having a net carrying amount of $0. As a result, the Company determined that it has acquired both tangible and intangible assets.

The table below summarizes the estimated fair value of the assets acquired and the liabilities assumed at the effective acquisition date.

 

Consideration     
Cash  $2,500,000 
      
Fair value of consideration transferred   2,500,000 
      
Recognized amounts of identifiable assets acquired and liabilities assumed:     
      
Right-of-use operating lease   98,638 
Total assets acquired   98,638 
      
Right-of-use operating lease   98,638 
Total liabilities assumed   98,638 
      
Total identifiable net assets   - 
      
Goodwill  $2,500,000 

 

At the time of acquisition, CLMI had nominal revenues and historical losses from operations. As a result, and given the immaterial nature of this acquisition, the Company elected not to present any pro-forma financial information.

 

This transaction did not involve the purchase of a “significant amount of assets” as defined in the Instructions to Item 2.01 of Form 8-K. Additionally, the acquisition of CLMI was not deemed to be significant to the Company at any level under SEC Regulation S-X 3.05 and did not require the presentation of any additional historical audited financial statements.

 

15

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

At June 30, 2025 and December 31, 2024 goodwill was $3,300,000, respectively.

 

At December 31, 2024, the Company determined that its subsidiary LogicsIQ would be considered a discontinued operation (See Note 1). Prior to this determination, and during the year ended December 31, 2024, the Company recorded a goodwill impairment loss of $866,782.

 

Note Receivable (Sale of Former Subsidiary)

 

On May 7, 2021, the Company disposed of its former subsidiary True Wireless, Inc.

 

In connection with the sale, the Company received an unsecured note receivable for $176,851, bearing interest at 0.6%, with a default interest rate of 10%. The Company was expected to receive twenty-five (25) monthly payments of principal and accrued interest totaling $7,461 commencing in June 2023.

 

Payments were scheduled as follows:

 

For the Year Ended December 31,      In Default 
2025   186,525**  $186,525 
    186,525      
Less: amount representing interest   (9,674)     
Total  $176,851      

 

** On July 12, 2023, Notice of Default was provided by SurgePays, Inc. to Blue Skies Connections, LLC for failure to pay amounts due under that certain Promissory Note dated June 14, 2021 by Blue Skies Connections, LLC in favor of SurgePays, Inc. in the original principal amount of $176,851 (the “Note”). Pursuant to the terms of the Note, SurgePays, Inc. accelerated the amount due.

 

As of June 30, 2025, the Company believes the note is collectible. See Note 8 for Contingencies – Legal Matters for additional discussion.

 

Business Segments and Concentrations

 

The Company uses the “management approach” to identify its reportable segments. The management approach requires companies to report segment financial information consistent with information used by management for making operating decisions and assessing performance as the basis for identifying the Company’s reportable segments. The Company manages its business as multiple reportable segments. See Note 10 regarding segment disclosure.

 

16

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

The Mobile Virtual Network Operator (SurgePhone and Torch Wireless) business segment made up approximately 21% and 89% of total consolidated revenues for the six months ended June 30, 2025 and 2024, respectively.

 

Revenues related to this business segment are 100% derived from programs administered by the Federal Communications Commission (FCC), and all funds related to these programs are received directly from organizations under the direction of the FCC and subject to administrative rulings, statutory changes, and other funding restrictions that could impact the Company’s operations in this segment.

 

Accounts receivable related to these programs made up 81% and 97% of accounts receivable at June 30, 2025 and December 31, 2024, respectively.

 

Use of Estimates

 

Preparing financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates, and those estimates may be material.

 

Significant estimates during the six months ended June 30, 2025 and 2024, respectively, include, allowance for doubtful accounts and other receivables, inventory reserves and classifications, valuation of loss contingencies, valuation of stock-based compensation, estimated useful lives related to property and equipment and intangible assets, capitalized internal-use software development costs, related impairment assessments of long lived assets, implicit interest rate in right-of-use operating leases, uncertain tax positions, income tax payable and the valuation allowance on deferred tax assets.

 

Risks and Uncertainties

 

The Company operates in an industry that is subject to intense competition and changes in consumer demand. The Company’s operations are subject to significant risk and uncertainties including financial and operational risks including the potential risk of business failure.

 

The Company has experienced, and in the future may experience, variability in sales and earnings. The factors expected to contribute to this variability include, among others, (i) the cyclical nature of the industry, (ii) general economic conditions in the various local markets in which the Company competes, including a potential general downturn in the economy, and (iii) the volatility of prices in connection with the Company’s distribution of the product. These factors, among others, make it difficult to project the Company’s operating results on a consistent basis.

 

17

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

Effective February 7, 2024, the Affordable Connectivity Program (“ACP”) stopped accepting new applications and enrollments. The program ceased funding on June 1, 2024. See discussion below regarding revenue recognition.

 

At December 31, 2024, the Company discontinued its lead generation services segment.

 

Fair Value of Financial Instruments

 

The Company accounts for financial instruments in accordance with Financial Accounting Standards Board (FASB) ASC 820, Fair Value Measurements, which provides a framework for measuring fair value and requires related disclosures. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company determines fair value based on its principal market or, if unavailable, the most advantageous market for the specific asset or liability.

 

To classify and disclose assets and liabilities measured at fair value, the Company utilizes a three-tier fair value hierarchy, which prioritizes observable inputs over unobservable ones:

 

Level 1 – Quoted market prices (unadjusted) for identical assets or liabilities in active markets.
Level 2 – Inputs other than quoted prices in active markets that are observable, either directly or indirectly, for similar assets or liabilities.
Level 3 – Unobservable inputs with minimal or no market data, requiring the Company to develop its own assumptions.

 

Determining fair value and assigning a measurement within the hierarchy involves judgment. Level 3 valuations, in particular, require greater judgment and complexity, as they may involve various valuation methods—such as cost, market, or income approaches—applied to management estimates and assumptions. These assumptions can include price estimates, earnings projections, market factors, or the weighting of different valuation methods. The Company may also engage external advisors to assist in fair value determinations when appropriate. While management believes recorded fair values are reasonable, they may not reflect future fair values or net realizable values.

 

The Company’s financial instruments, including cash, accounts receivable, note receivable, accounts payable, and accrued expenses (including related-party amounts), are recorded at historical cost. As of June 30, 2025 and December 31, 2024, the carrying values of these instruments approximate their fair values due to their short-term nature.

 

18

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

Additionally, ASC 825-10, Financial Instruments, allows entities to elect the fair value option, enabling financial assets and liabilities to be measured at fair value on an instrument-by-instrument basis. This election is irrevocable unless a new election date occurs, and any unrealized gains or losses would be recognized in earnings at each reporting date. The Company has not elected to apply the fair value option to any outstanding financial instruments.

 

Cash and Cash Equivalents, Restricted Cash and Concentration of Credit Risk

 

For purposes of the consolidated statements of cash flows, the Company considers all highly liquid instruments with a maturity of three months or less at the purchase date and money market accounts to be cash equivalents.

 

The Company is exposed to credit risk on its cash and cash equivalents in the event of default by the financial institutions to the extent account balances exceed the amount insured by the FDIC, which is $250,000.

 

At June 30, 2025 and December 31, 2024, respectively, the Company did not experience any losses on cash balances in excess of FDIC insured limits.

 

Additionally, at June 30, 2025 and December 31, 2024, the Company had $0 and $1,000,000, respectively, held in escrow, that was restricted in connection with a potential acquisition. The restriction lapsed in January 2025, and the $1,000,000 was returned to the Company’s operating cash account.

 

Marketable Securities - Classification and Valuation

 

The Company may classify its marketable securities as either trading, available-for-sale, or held-to-maturity.

 

Trading securities are recorded at fair value with unrealized gains and losses included in earnings.

 

Available-for-sale securities are recorded at fair value with unrealized gains and losses excluded from earnings and reported in other comprehensive income.

 

Held-to-maturity securities are recorded at amortized cost.

 

At December 31, 2024, the Company classified all of its marketable securities as trading, based upon our intent to sell them in the near term. Our securities consist of U.S. Treasury and government exchange traded funds.

 

At December 31, 2024, the Company’s marketable securities were $0.

 

19

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

Marketable securities were as follows at December 31, 2024:

 

   U.S. Treasury & Government 
   Exchange Traded Funds 
   Fixed Income 
Balance - December 31, 2023  $- 
Purchases   10,000,000 
Sales   (10,173,057)
Realized gains   13,613 
Dividends, interest and other income   169,306 
Fees/adjustments   (9,862)
Balance - December 31, 2024  $- 

 

Impairment of Marketable Securities

 

The Company evaluates its marketable securities for impairment at each reporting period.

 

An impairment is considered to be other-than-temporary if the Company (a) intends to sell the security, (b) is more likely than not to be required to sell the security before recovery of its amortized cost basis, or (c) does not expect to recover the entire amortized cost basis of the security.

 

If a decline in fair value is determined to be other-than-temporary, the impairment loss is recognized in earnings. For debt securities, the amount of the other-than-temporary impairment recognized in earnings depends on the extent to which the security’s fair value is less than its amortized cost and the severity and duration of the decline.

 

The determination of whether a decline is other-than-temporary involves significant judgment and includes an assessment of various factors including:

 

The length of time and the extent to which the fair value has been less than the cost basis;
The financial condition and near-term prospects of the issuer, including any specific events that may influence the issuer’s operations or profitability;
The intent and ability of the Company to hold the security for a period of time sufficient to allow for any anticipated recovery in fair value.

 

The Company did not record any impairment losses related to its marketable securities.

 

See Note 7 for additional disclosure of our marketable securities at fair value.

 

20

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

Accounts Receivable

 

Accounts receivable are stated at the amount management expects to collect from outstanding customer balances. Credit is extended to customers based on an evaluation of their financial condition and other factors. Interest is not accrued on overdue accounts receivable. The Company does not require collateral.

 

Management periodically assesses the Company’s accounts receivable and, if necessary, establishes an allowance for estimated uncollectible amounts. The Company provides an allowance for doubtful accounts based upon a review of the outstanding accounts receivable, historical collection information and existing economic conditions. Accounts determined to be uncollectible are charged to operations when that determination is made.

 

Allowance for doubtful accounts was $0 at June 30, 2025 and December 31, 2024, respectively.

 

There was bad debt expense (recovery) of $0 for the three and six months ended June 30, 2025 and 2024, respectively.

 

Bad debt expense (recoveries) is recorded as a component of general and administrative expenses in the accompanying consolidated statements of operations.

 

Inventory

 

Inventory primarily consists of cell phones and store racking. Inventories are stated at the lower of cost or net realizable value using the average cost valuation method.

 

During the year ended December 31, 2024, and in connection with the cessation of the ACP Program on June 1, 2024, the Company wrote off inventory totaling $6,382,471.

 

At June 30, 2025 and December 31, 2024, the Company had inventory of $2,410,817 and $1,781,365, respectively.

 

Impairment of Long-lived Assets

 

Management evaluates the recoverability of the Company’s identifiable intangible assets and other long-lived assets when events or circumstances indicate a potential impairment exists, in accordance with the provisions of ASC 360-10-35-15 “Impairment or Disposal of Long-Lived Assets.” Events and circumstances considered by the Company in determining whether the carrying value of identifiable intangible assets and other long-lived assets may not be recoverable, but are not limited to significant changes in performance relative to expected operating results; significant changes in the use of the assets; significant negative industry or economic trends; and changes in the Company’s business strategy. In determining if impairment exists, the Company estimates the undiscounted cash flows to be generated from the use and ultimate disposition of these assets.

 

21

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

If impairment is indicated based on a comparison of the assets’ carrying values and the undiscounted cash flows, the impairment to be recognized is measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets.

 

There were no impairment losses for the three and six months ended June 30, 2025 and 2024, respectively.

 

Property and Equipment

 

Property and equipment is stated at cost less accumulated depreciation. Depreciation is provided on the straight-line basis over the estimated useful lives of the assets.

 

Expenditures for repair and maintenance which do not materially extend the useful lives of property and equipment are charged to operations. When property or equipment is sold or otherwise disposed of, the cost and related accumulated depreciation are removed from the respective accounts with the resulting gain or loss reflected in operations.

 

Management reviews the carrying value of its property and equipment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable.

 

There were no impairment losses for the three and six months ended June 30, 2025 and 2024, respectively.

 

Internal Use Software Development Costs

 

We capitalize certain internal use software development costs associated with creating and enhancing internally developed software related to our technology infrastructure. These costs include personnel and related employee benefits expenses for employees who are directly associated with and who devote time to software projects, and external direct costs of materials and services consumed in developing or obtaining the software. Software development costs that do not meet the qualification for capitalization, as further discussed below, are expensed as incurred and recorded in general and administrative expenses in the consolidated results of operations.

Software development activities generally consist of three stages:

 

(i)planning stage,
(ii)application and infrastructure development stage, and
(iii)post implementation stage.

 

22

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

Costs incurred in the planning and post implementation stages of software development, including costs associated with the post-configuration training and repairs and maintenance of the developed technologies, are expensed as incurred.

 

We capitalize costs associated with software developed for internal use when the planning stage is completed, management has authorized further funding for the completion of the project, and it is probable that the project will be completed and perform as intended. Costs incurred in the application and infrastructure development stages, including significant enhancements and upgrades, are capitalized. Capitalization ends once a project is substantially complete, and the software and technologies are ready for their intended purpose. There is judgment involved in estimating the stage of development as well as estimating time allocated to a particular project. A significant change in the time spent on each project could have a material impact on the amount capitalized and related amortization expense in subsequent periods.

 

We amortize internal use software development costs using a straight-line method over a three-year (3) estimated useful life, commencing when the software is ready for its intended use. The straight-line recognition method approximates the manner in which the expected benefit will be derived. We determined the life of internal use software based on historical software upgrades and replacement.

 

On an ongoing basis, we assess if the estimated remaining useful lives of capitalized projects continue to be reasonable based on the remaining expected benefit and usage. If the remaining useful life of a capitalized project is revised, it is accounted for as a change in estimate and the remaining unamortized cost of the underlying asset is amortized prospectively over the updated remaining useful life.

We also evaluate internal use software for abandonment and use that as a significant indicator for impairment on a quarterly basis.

 

At December 31, 2024, the Company determined that there was no future use for its capitalized internal use software development costs based upon its current and expected future operations. As a result, the Company recorded an impairment loss of $316,594.

 

Right of Use Assets and Lease Obligations

 

The Right of Use Asset and Lease Liability reflect the present value of the Company’s estimated future minimum lease payments over the lease term, which may include options that are reasonably assured of being exercised, discounted using a collateralized incremental borrowing rate.

 

23

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

Typically, renewal options are considered reasonably assured of being exercised if the associated asset lives of the building or leasehold improvements exceed that of the initial lease term, and the performance of the business remains strong. Therefore, the Right of Use Asset and Lease Liability may include an assumption on renewal options that have not yet been exercised by the Company. The Company’s operating leases contained renewal options that expire at various dates with no residual value guarantees. Future obligations relating to the exercise of renewal options is included in the measurement if, based on the judgment of management, the renewal option is reasonably certain to be exercised. Factors in determining whether an option is reasonably certain of exercise include, but are not limited to, the value of leasehold improvements, the value of the renewal rate compared to market rates, and the presence of factors that would cause a significant economic penalty to the Company if the option is not exercised. Management reasonably plans to exercise all options, and as such, all renewal options are included in the measurement of the right-of-use assets and operating lease liabilities.

 

As the rate implicit in leases are not readily determinable, the Company uses an incremental borrowing rate to calculate the lease liability that represents an estimate of the interest rate the Company would incur to borrow on a collateralized basis over the term of a lease within a particular currency environment. See Note 8 regarding operating leases.

 

Revenue Recognition

 

The Company recognizes revenue in accordance with ASC 606 to align revenue recognition more closely with the delivery of the Company’s services and will provide financial statement readers with enhanced disclosures. In accordance with ASC 606, revenue is recognized when a customer obtains control of promised services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for these services.

 

To achieve this core principle, the Company applies the following five steps:

 

Step 1: Identify the contract(s) with customers

Step 2: Identify the performance obligations in the contract

Step 3: Determine the transaction price

Step 4: Allocate the transaction price to performance obligations

Step 5: Recognize revenue when the entity satisfies a performance obligation

 

Identify the contract with a customer

 

A contract with a customer exists when (i) the Company enters into an enforceable contract with a customer that defines each party’s rights regarding the services to be transferred and identifies the payment terms related to these services, (ii) the contract has commercial substance and, (iii) the Company determines that collection of substantially all consideration for services that are transferred is probable based on the customer’s intent and ability to pay the promised consideration. The Company applies judgment in determining the customer’s ability and intention to pay, which is based on a variety of factors including the customer’s historical payment experience or, in the case of a new customer, published credit and financial information pertaining to the customer.

 

24

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

Identify the performance obligations in the contract

 

Performance obligations promised in a contract are identified based on the services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the service either on its own or together with other resources that are readily available from third parties or from the Company, and are distinct in the context of the contract, whereby the transfer of the services is separately identifiable from other promises in the contract. To the extent a contract includes multiple promised services, the Company must apply judgment to determine whether promised services are capable of being distinct and distinct in the context of the contract. If these criteria are not met the promised services are accounted for as a combined performance obligation.

 

Determine the transaction price

 

The transaction price is determined based on the consideration to which the Company will be entitled in exchange for transferring services to the customer. To the extent the transaction price includes variable consideration, the Company estimates the amount of variable consideration that should be included in the transaction price utilizing either the expected value method or the most likely amount method depending on the nature of the variable consideration. Variable consideration is included in the transaction price if, in the Company’s judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. None of the Company’s contracts contain a significant financing component and there are no contracts with variable consideration.

 

Allocate the transaction price to performance obligations in the contract

 

If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. However, if a series of distinct services that are substantially the same qualifies as a single performance obligation in a contract with variable consideration, the Company must determine if the variable consideration is attributable to the entire contract or to a specific part of the contract. For example, a bonus or penalty may be associated with one or more, but not all, distinct services promised in a series of distinct services that forms part of a single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative standalone selling price basis unless the transaction price is variable and meets the criteria to be allocated entirely to a performance obligation or to a distinct service that forms part of a single performance obligation. The Company determines standalone selling price based on the price at which the performance obligation is sold separately. If the standalone selling price is not observable through past transactions, the Company estimates the standalone selling price taking into account available information such as market conditions and internally approved pricing guidelines related to the performance obligations.

 

25

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

Recognize revenue when or as the Company satisfies a performance obligation

 

The Company satisfies performance obligations either over time or at a point in time. Revenue is recognized at the time the related performance obligation is satisfied by transferring a promised service to a customer.

 

The following reflects additional discussion regarding our revenue recognition policies for each of our material revenue streams. For each revenue stream we do not offer any returns, refunds or warranties, and no arrangements are cancellable. Additionally, all contract consideration is fixed and determinable at the initiation of the contract.

 

Performance obligations for Torch and LogicsIQ are satisfied when services are performed. Performance obligations for ECS and SB are satisfied at point of sale. For each of our revenue streams we only have a single performance obligation.

 

Mobile Virtual Network Operators

 

Torch Wireless is licensed to provide subsidized mobile broadband services through the Lifeline program to qualifying low-income customers. Revenue is recognized when the Company satisfies its performance obligation by providing eligible service to active Lifeline subscribers as of the last day of each month.

 

At the end of each month, the Company determines the number of active Lifeline users based on internal usage data and eligibility status. A report is submitted to the Universal Service Administrative Company (USAC) for review and approval. Upon submission, the Company has fulfilled its performance obligation, and accordingly, revenue and accounts receivable are recognized.

 

Revenue is recorded in the month in which the Lifeline service was provided and the subscriber remained active at month-end, regardless of when payment is received. Payment is typically received by the 28th of the following month.

 

Lead Generation Services

 

LogicsIQ, Inc. was a lead generation and case management solutions company primarily serving law firms in the mass tort industry. Revenues were earned from our lead generation retained services offerings and call center activities.

 

Effective January 1, 2024, the Company no longer provided these services.

 

Effective December 31, 2024, the Company’s management elected to abandon its lead generation segment operations as part of a strategic reassessment of its business lines. See Note 1.

 

Additionally, the segment disclosure for this former segment is now combined as a part of other corporate overhead.

 

26

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

Point-of-Sale and Prepaid Services

 

Revenues are generated through the sale of telecommunication products such as mobile phones, wireless top-up refills, and other mobile related products. At the time in which our products are sold through our online web portal (point of sale), our performance obligation is considered complete. At point of sale (completion of performance obligation), our web portal platform initiates an automated clearing house transaction (ACH) resulting in the recording revenue.

 

The Company has evaluated revenue recognition and related disclosures and has determined the Company is a principal in these arrangements. As a result, we record all revenues at their gross amounts and the related costs are recorded as costs of revenues in the accompanying consolidated financial statements.

 

Contract Liabilities (Deferred Revenue)

 

Contract liabilities represent deposits made by customers before the satisfaction of performance obligation and recognition of revenue. Upon completion of the performance obligation(s) that the Company has with the customer based on the terms of the contract, the liability for the customer deposit is relieved and revenue is recognized.

 

At June 30, 2025 and December 31, 2024, the Company had deferred revenue of $0, respectively.

 

The following represents the Company’s disaggregation of revenues for the six months ended June 30, 2025 and 2024:

 

   For the Six Months Ended June 30, 
   2025   2024 
                 
Revenue  Revenue   % of Revenues   Revenue   % of Revenues 
                 
Mobile Virtual Network Operators  $4,559,530    20.64%  $41,396,096    89.00%
Point-of-Sale and Prepaid Services   17,536,066    79.36%   5,107,409    10.98%
Other Corporate Overhead   -    0.00%   11,329    0.02%
Total Revenues  $22,095,596    100.00%  $46,514,834    100.00%

 

The above disaggregation of revenues includes the following entities:

 

Mobile Virtual Network Operators (SPW and TW),

Point-of-Sale and Prepaid Services (Surge Fintech and ECS); and

Other Corporate Overhead (Surge Blockchain and formerly LogicsIQ and Injury Survey)

 

27

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

Effective December 31, 2024, the Company’s management elected to abandon its lead generation segment operations as part of a strategic reassessment of its business lines. See Note 1. As a result, segment reporting/disaggregation of revenues for lead generation was no longer required and have now been included as a component of “other corporate overhead”.

 

Cost of Revenues

 

Cost of revenues consists of tablet purchases, mobile phone purchases, purchased telecom services including data usage and access to wireless networks. Additionally, cost of revenues consists of call center costs, prepaid phone cards, commissions, and advertising costs.

 

Income Taxes

 

The Company accounts for income tax using the asset and liability method prescribed by ASC 740, “Income Taxes”. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes the enactment date.

 

The Company follows the accounting guidance for uncertainty in income taxes using the provisions of ASC 740 “Income Taxes”. Using that guidance, tax positions initially need to be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. As of June 30, 2025 and December 31, 2024, respectively, the Company had no uncertain tax positions that qualify for either recognition or disclosure in the financial statements.

 

The Company recognizes interest and penalties related to uncertain income tax positions in other expense. No interest and penalties related to uncertain income tax positions were recorded for the three and six months ended June 30, 2025 and 2024, respectively.

 

As of June 30, 2025, the loss resulted in the Company being in a three-year cumulative historic loss position. As a result, the Company recorded a full valuation allowance on its deferred tax assets as of June 30, 2025 and December 31, 2024.

 

The Company currently has an unapplied net operating loss carryforward (deferred tax asset), which have been evaluated for applicability in offsetting current taxable net income. The Company has determined that the federal net operating loss carryforward is limited to 80% of the current year’s net taxable income. Since the Company entered a three-year cumulative loss during the six months ended June 30, 2025, a full valuation allowance has been recorded against all net operating loss carryforwards.

 

28

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

Investment

 

On January 17, 2019, we announced the completion of an agreement to acquire a 40% equity ownership of CenterCom Global, S.A. de C.V. (“CenterCom”). CenterCom is a dynamic operations center currently providing sales support, customer service, IT infrastructure design, graphic media, database programming, software development, revenue assurance, lead generation, and other various operational support services. Our CenterCom team is based in El Salvador. CenterCom also provides call center support for various third-party clients.

 

The strategic partnership with CenterCom as a bilingual operations hub has powered our growth and revenue. CenterCom has been built to support the infrastructure required to rapidly scale in synergy and efficiency to support our sales growth, customer service and development.

 

We account for this investment under the equity method. Investments accounted for under the equity method are recorded based upon the amount of our investment and adjusted each period for our share of the investee’s income or loss. All investments are reviewed for changes in circumstance or the occurrence of events that suggest an other than temporary event where our investment may not be recoverable. The financial information used to account for the investment is unaudited.

 

The following is a summary of our investment at December 31, 2024:

 

Balance - December 31, 2023  $464,409 
Gain on investment in CenterCom   33,864 
Impairment loss - CenterCom   (498,273)
Balance - December 31, 2024  $- 

 

During the three and six months ended June 30 2024, we recognized a gain of $17,711 and 33,864, respectively.

 

As of December 31, 2024, The Company determined that it would no longer utilize the Business Process Outsourcing (BPO) services of CenterCom. As of December 31, 2024, the Company assessed its investment in CenterCom and determined there was an impairment. Factors leading to this decision included a change in ownership and large reduction in human capital. As a result, CenterCom was materially impacted and could no longer continue its operations.

 

As a result, for the year ended December 31, 2024, the Company recorded an impairment loss of $498,273.

 

29

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

Advertising Costs

 

Advertising costs are expensed as incurred. Advertising costs are included as a component of general and administrative expense in the consolidated statements of operations.

 

The Company recognized marketing and advertising costs during the three and six months ended June 30, 2025 and 2024, respectively, as follows:

 

For the Three Months Ended June 30,   For the Six Months Ended June 30, 
2025   2024   2025   2024 
$14,143   $11,044   $37,623   $27,851 

 

Stock-Based Compensation

 

The Company accounts for stock-based compensation in accordance with ASC 718, “Compensation – Stock Compensation”, as amended by ASU 2018-07 – Improvements to Nonemployee Share-Based Payment Accounting. Under the fair value-based method:

 

Compensation cost is measured at the grant date based on the fair value of the award.
The cost is recognized over the service period, typically the vesting period.
This guidance applies to transactions where equity instruments are exchanged for goods or services and also addresses liabilities settled in equity instruments.

 

For equity instruments granted to non-employees, the Company applies the fair value method, using the Black-Scholes option pricing model to measure the fair value of stock options.

 

The fair value of stock-based compensation is determined either:

 

At the grant date, or
At the measurement date, when performance obligations are fulfilled.

 

Assumptions Used in Fair Value Determination

 

When using the Black-Scholes model, the Company considers the following key assumptions, in accordance with ASU 2017-09 – Compensation – Stock Compensation (Topic 718): Scope of Modification Accounting:

 

Exercise price
Expected dividend yield
Expected stock price volatility
Risk-free interest rate
Expected life of the option

 

30

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

Stock Warrants

 

The Company may issue warrants to purchase shares of its common stock in connection with financing transactions (debt or equity), consulting agreements, and collaboration arrangements.

 

Classification: Warrants are classified as equity awards when they are standalone instruments that are neither puttable nor mandatorily redeemable, as per ASC 815-40 – Derivatives and Hedging: Contracts in Entity’s Own Equity.
Valuation: The fair value of compensatory warrants is determined using the Black-Scholes option pricing model at the measurement date.
Derivative Liabilities: If a warrant meets the definition of a derivative liability, fair value is determined using a binomial pricing model, in accordance with ASC 815-40.

 

Accounting Treatment

 

Warrants issued in conjunction with common stock are recorded at fair value as a reduction to additional paid-in capital of the issued stock, in accordance with ASC 718 and ASC 815.
Warrants issued for services are recorded at fair value and expensed either:

 

Over the requisite service period, or
Immediately at issuance if no service period is required.

 

Basic and Diluted Earnings (Loss) per Share

 

The Company computes earnings (loss) per share in accordance with ASC 260-10-45, Earnings Per Share, as amended by ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity.

 

Basic earnings (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the reporting period.
Diluted earnings per share includes the impact of potentially dilutive securities, calculated by dividing net income by the weighted average number of common shares outstanding, common stock equivalents, and other potentially dilutive securities during the period.

 

Potentially Dilutive Securities

 

Potentially dilutive common shares include:

 

Contingently issuable shares
Common stock issuable upon the exercise of stock options and warrants, calculated using the treasury stock method in accordance with ASC 260-10-55
Convertible debt instruments, if applicable

 

31

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

These securities may be dilutive in the future, but in periods where the Company reports a net loss, diluted loss per share is equal to basic loss per share because the inclusion of potential common stock equivalents would be anti-dilutive.

 

Outstanding Potentially Dilutive Equity Securities

 

The following potentially dilutive equity securities were outstanding as of June 30, 2025 and 2024:

 

   June 30, 2025   June 30, 2024 
Warrants   703,000    3,619,278 
Stock options   1,166,081    121,276 
Total common stock equivalents   1,869,081    3,740,554 

 

Warrants and stock options included as common stock equivalents represent those that are fully vested and exercisable. See Note 9.

 

Sufficiency of Authorized Shares

 

As of June 30, 2025 and December 31, 2024, the Company has 500,000,000 authorized shares of common stock, which is sufficient to accommodate any potential exercises of common stock equivalents.

 

During the six months ended June 30, 2025, the Company reacquired 333,333 shares of treasury stock for $999,999 ($3/share), in connection with a third party convertible debt lender (See Note 6).

 

During the year ended December 31, 2024, the Company reacquired 362,620 shares of treasury stock for $631,967.

 

Treasury shares are excluded from the denominator in computing basic and diluted earnings (loss) per share, as these shares are not considered outstanding.

 

Treasury Stock

 

The Company accounts for treasury stock under the cost method, which records treasury stock at the purchase price and presents it as a reduction in stockholders’ equity. Under this method, the purchase, sale, issuance, or retirement of treasury stock does not impact the income statement. Gains or losses on the reissuance of treasury stock are reflected as adjustments to additional paid-in capital. In cases where additional paid-in capital is insufficient to cover a loss, the remaining balance is charged to retained earnings.

 

32

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

Treasury stock is initially recorded at cost on the date of repurchase. If treasury shares are subsequently reissued, they are removed from treasury stock at the cost at which they were originally acquired. Any excess of the reissuance price over cost is credited to additional paid-in capital, while any deficiency is charged to additional paid-in capital to the extent of previously recorded credits, with any remaining deficiency charged to retained earnings.

 

The Company periodically assesses the need to retain treasury shares and may retire shares if they are no longer deemed necessary for future use, resulting in a reduction of issued shares and a corresponding adjustment to retained earnings.

 

Related Parties

 

The Company identifies and discloses related party relationships and transactions in accordance with ASC 850, “Related Party Disclosures”, and follows guidance set forth by the SEC under Regulation S-X, Rule 4-08(k) regarding related party disclosures.

 

A party is considered related to the Company if it meets any of the following criteria:

 

Directly or indirectly controls, is controlled by, or is under common control with the Company.

 

Principal owners, including any entity or individual that holds a significant ownership interest in the Company.

 

Management and key personnel, including officers, directors, and executives.

 

Immediate family members of principal owners and key management personnel.

 

Entities with significant influence, where one party can exert control or influence over the management or operating policies of another party to the extent that one of the transacting parties may not be fully pursuing its own separate economic interests.

 

The Company follows the SEC’s Regulation S-K, Item 404(a), which requires the disclosure of related party transactions exceeding a materiality threshold and details on the nature of the relationship, transaction terms, and amounts involved.

 

During the six months ended June 30, 2025 and 2024, respectively, the Company incurred expenses with a related party (annual rental agreement) in the normal course of business as follows:

 

Related Party  June 30, 2025   June 30, 2024 
Carddawg Investments, Inc.   83,178    83,178 1
Total  $83,178   $83,178 

 

1- represents an affiliate of our Chief Executive Officer (Kevin Brian Cox)

 

33

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

From time to time, the Company may use credit cards to pay corporate expenses, these credit cards are in the names of certain of the Company’s officers and directors. These amounts are insignificant.

 

See Note 6 for debt transactions with our Chief Executive Officer.

 

Recent Accounting Standards

 

The Financial Accounting Standards Board (FASB) establishes changes to accounting principles through Accounting Standards Updates (ASUs), which amend the FASB Codification. The Company evaluates the applicability and impact of all newly issued ASUs on its consolidated financial position, results of operations, stockholders’ equity, and cash flows.

 

Management has assessed all recent accounting pronouncements issued through the date these financial statements were available for issuance. Except as described below, no newly issued but not yet effective accounting pronouncements are expected to have a material impact on the Company’s consolidated financial statements.

 

Recently Adopted Accounting Standards

 

ASU 2023-01, Leases (Topic 842): Common Control Arrangements

Issued: March 2023
Effective Date: For fiscal years beginning after December 15, 2023
Summary: This ASU clarifies leasehold improvements accounting for entities under common control and requires leasehold improvements to be amortized over the useful life of the improvements rather than the lease term.
Expected Impact: The Company adopted ASU 2023-01 on January 1, 2024, and the adoption did not have a material impact on the Company’s consolidated financial statements.

 

ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures

Issued: November 2023
Effective Date: For fiscal years beginning after December 15, 2023
Summary: Enhances segment reporting disclosures, requiring more information about significant segment expenses.
Expected Impact: The Company adopted ASU 2023-07 on January 1, 2024, and the adoption did not have a material impact on the Company’s consolidated financial statements.

 

34

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures

Issued: December 2023
Effective Date: For fiscal years beginning after December 15, 2024
Summary: Expands disclosure requirements related to income taxes, including greater detail on income tax rate reconciliations and disaggregation of tax expense components.
Expected Impact: The Company adopted ASU 2023-09 on January 1, 2025, and the adoption did not have a material impact on the Company’s consolidated financial statements.

 

Other Recent Updates

 

Various other ASUs have been issued that primarily contain technical corrections or industry-specific guidance. These updates are not expected to have a material impact on the Company’s consolidated financial position, results of operations, or cash flows.

 

Reclassifications

 

Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no material effect on the consolidated results of operations, stockholders’ equity, or cash flows.

 

Note 3 – Property and Equipment

 

Property and equipment consisted of the following:

 

Type  June 30, 2025   December 31, 2024   Estimated Useful Lives (Years)
            
Computer equipment and software  $1,135,178   $1,135,178   3 - 5
Leasehold improvements   324,901    306,311   5
Furniture and fixtures   165,738    165,738   5 - 7
Property and Equipment - gross   1,625,817    1,607,227    
Less: accumulated depreciation/amortization   (1,168,622)   (1,016,139)   
Property and equipment - net  $457,195   $591,088    

 

Depreciation and amortization expense for the three months ended June 30, 2025 and 2024, were $66,365 and $70,383, respectively.

 

Depreciation and amortization expense for the six months ended June 30, 2025 and 2024, were $152,483 and $140,766, respectively.

 

35

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

These amounts are included as a component of general and administrative expenses in the accompanying consolidated statements of operations.

 

Note 4 – Intangibles

 

Intangibles consisted of the following:

 

 

Type  June 30, 2025   December 31, 2024   Estimated Useful Lives (Years)
            
Proprietary Software  $4,286,402   $4,286,402   7
Tradenames/trademarks   617,474    617,474   15
ECS membership agreement   465,000    465,000   1
Noncompetition agreement   201,389    201,389   2
Customer Relationships   183,255    183,255   5
Intangibles - gross   5,753,520    5,753,520    
Less: accumulated amortization   (4,607,764)   (4,280,558)   
Intangibles - net  $1,145,756   $1,472,962    

 

Amortization expense for the three and six months ended June 30, 2025 and 2024 was as follows:

 

 

Three Months Ended 
June 30, 2025   June 30, 2024 
$163,452   $163,377 

 

Six Months Ended 
June 30, 2025   June 30, 2024 
$327,206   $326,754 

 

Estimated amortization expense for each of the succeeding years is as follows:

 

 

For the Years Ended December 31:    
2025 (6 months)   326,754 
2026   653,508 
2027   165,494 
Total  $1,145,756 

 

36

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

Note 5 – Internal Use Software Development Costs

 

Internal Use Software Development Costs consisted of the following:

 

 

Type  December 31, 2024 
     
Internal use software development costs  $668,484 
Less: accumulated amortization   (351,890)
Less: impairment loss   (316,594)
Internal Use Software Development Costs - net  $- 

 

Costs incurred for Internal Use Software Development Costs

 

At December 31, 2024, the Company determined that there was no future use for its capitalized internal use software development costs based upon its current and expected future operations. As a result, the Company recorded an impairment loss of $316,594 and removed the gross amount of its capitalized costs totaling $668,484. See Note 1.

 

For the three months ended June 30, 2024, amortization of internal software development costs was $55,707.

 

For the six months ended June 30, 2024, amortization of internal software development costs was $111,414.

 

Note 6 – Debt

 

The following represents a summary of the Company’s notes payable – SBA government, notes payable – related parties, and notes payable, key terms, and outstanding balances at June 30, 2025 and December 31, 2024, respectively:

 

Notes Payable – SBA government

 

Economic Injury Disaster Loan (“EIDL”)

 

During 2020, this program was made available to eligible borrowers in light of the impact of the COVID-19 pandemic and the negative economic impact on the Company’s business. Proceeds from the EIDL were used for working capital purposes.

 

Installment payments, including principal and interest, are due monthly (beginning twelve (12) months from the date of the promissory note) in amounts ranging from $74 - $731/month. The balance of principal and interest is payable over the next thirty (30) years from the date of the promissory note. There are no penalties for prepayment. The EIDL Loan was not required to be refinanced by the PPP loan.

 

37

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

   EIDL   EIDL     
Terms  SBA   SBA   Total 
           
Issuance dates of SBA loans   May 2020    July 2020      
Term   30 Years    30 Years      
Maturity date   May 2050    July 2050      
Interest rate   3.75%   3.75%     
Collateral   Unsecured    Unsecured      
                
Balance - December 31, 2023   141,994    318,529    460,523 
Interest expense adjustment - SBA loans   5,487    14,263    19,750 
Repayments   (3,532)   (7,345)   (10,877)
Balance - December 31, 2024   143,949    325,447    469,396 
Repayments   (1,722)   (3,790)   (5,512)
Balance - June 30, 2025  $142,227   $321,657   $463,884 

 

Notes Payable – Related Parties

 

 

The following is a summary of the Company’s Notes Payable - Related Parties:

 

   1   1   Total 
Balance - December 31, 2023   -    4,584,563    4,584,563 
Reclassification of principal into one single note   4,584,563    (4,584,563)   - 
Reclassification of accrued interest payable into one single note   498,991    -    498,991 
Repayments   (1,527,899)   -    (1,527,899)
Balance - December 31, 2024   3,555,655    -    3,555,655 
Repayments   (684,419)   -    (684,419)
Balance - June 30, 2025  $2,871,236   $-   $2,871,236 

 

1Activity is with the Company’s Chief Executive Officer and Board Member (Kevin Brian Cox).

 

On March 12, 2024, as approved by the Audit Committee, the Company consolidated all remaining outstanding principal ($4,584,563) and accrued interest payable ($498,991) into one note totaling $5,083,554. This note bears interest at 10% (with a default interest rate of 15%) and will be repaid ratably over a period of 36 months aggregating $5,905,427 in total payments to be made (inclusive of interest). Each monthly payment will be $164,039. The note is unsecured. The Note is expected to be repaid in full by December 2026.

 

38

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

The following is a detail of the Company’s Notes Payable - Related Parties:

 

 

Note Payable - Related Party
Note Holder  Issue Date  Maturity Date  Interest Rate   Default Interest Rate   Collateral  June 30, 2025   December 31, 2024 
Note #1  December 31, 2023  December 31, 2026   10.00%   15.00%  None  $2,871,236   $3,555,655 
                   Short Term   1,915,331    1,689,367 
                   Long Term  $955,905   $1,866,288 

 

Senior Secured Convertible Note and Warrants

 

Convertible Note Issuance

 

On May 12, 2025, the Company entered into a Senior Secured Note Purchase Agreement with Funicular Funds, LP (the “Investor”), pursuant to which the Company issued a Senior Secured Convertible Note in the original principal amount of $6,999,999 (the “Note”). The transaction resulted in net cash proceeds of $6,000,000 to the Company and included the repurchase of 333,333 shares of the Company’s common stock from the Investor at $3/share. These repurchased shares will be cancelled and retired, and the corresponding shares will not be returned to the pool of authorized but unissued shares, and remain as treasury stock. See Note 9.

 

The Note is secured by a first-priority lien on substantially all of the Company’s and its subsidiaries’ assets pursuant to a Security and Pledge Agreement, and is fully guaranteed by certain subsidiaries of the Company.

 

Interest and Amortization Terms

 

The Note accrues interest at a rate of 1.25% per month (15% per annum). Interest is payable monthly, either in cash or in-kind (“PIK Interest”) at the Company’s election. Beginning January 31, 2026, the Company is required to make monthly principal payments of $500,000, with the remaining balance due on the Note’s maturity date of May 12, 2027, unless earlier repaid, redeemed, or converted.

 

Embedded Conversion Feature

 

The Note includes an embedded conversion option, which permits the Investor to convert the outstanding principal and accrued interest into shares of the Company’s common stock at an initial conversion price of $4.00 per share.

 

39

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

Warrant Issuance and Classification

 

In connection with the issuance of the Note, the Company also issued warrants to purchase 700,000 shares of its common stock at an exercise price of $6/share. The warrants are immediately exercisable and remain outstanding through May 12, 2030.

 

Debt Discount

 

In connection with the issuance of the $6,999,999 convertible promissory note, the Company issued warrants to purchase 700,000 shares of common stock. The Company allocated a portion of the proceeds to the warrants based on their relative fair value, determined using the Black-Scholes option pricing model. The fair value of the warrants was estimated to be $207,640, which was recorded as a component of the total debt discount and is being amortized to interest expense over the term of the note. The Company also recorded a corresponding increase to additional paid-in capital of $207,640.

 

The fair value of the warrants was determined using the Black-Scholes model with the following assumptions:

 

Expected term (years)   5 
Expected volatility   105%
Expected dividends   0%
Risk free interest rate   4.09%

 

In addition to the warrants, the Company incurred direct debt issuance costs of $595,000, which were also recorded as part of the debt discount.

 

As a result, the Company recorded a total debt discount of $802,640, consisting of $207,640 related to the warrants and $595,000 related to direct offering costs. The debt discount will be fully amortized over the contractual term of the note (2 years).

 

40

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

The following is a summary of the Company’s Convertible Note Payable:

 Schedule of convertible debt 

   Total 
Balance - December 31, 2024  $- 
Proceeds from issuance of note   6,000,000 
Increase in note balance - common stock repurchase ($3/share)   999,999 
Debt discount   (802,640)
Amortization of debt discount   66,887 
Balance - June 30, 2025  $6,264,246 
      
Unamortized debt discount  $735,753 

 

The following is a detail of the Company’s Convertible Note Payable:

 

Convertible Note Payable - Net
Note Holder  Issue Date  Maturity Date  Interest Rate   Default Interest Rate  Collateral 

June 30,

2025

   December 31, 2024 
 Note #1  May 12, 2025  May 12, 2027   15.00%  N/A  All assets  $6,999,999   $         - 
                 Less: unamortized debt discount   (735,753)   - 
                 Convertible note payable - net   6,264,246    - 
                 Short Term   1,430,267    - 
                 Long Term  $4,833,979   $- 

 

Debt Maturities

 

The following represents the maturities of the Company’s various debt arrangements for each of the five (5) succeeding years and thereafter as follows:

 

 

For the Year Ended December 31,  Notes Payable - Related Parties   Notes Payable - SBA Government   Convertible Note Payable   Total 
                 
2025 (6 months)  $1,915,331   $5,531   $-   $1,920,862 
2026   955,905    11,461    4,519,727    5,487,093 
2027   -    11,902    2,480,272    2,492,174 
2028   -    12,308    -    12,308 
2029   -    12,820    -    12,820 
Thereafter   -    409,862    -    409,862 
Total   2,871,236    463,884    6,999,999    10,335,119 
Less: unamortized debt discount   -    -    735,753    735,753 
Debt - net  $2,871,236   $463,884   $6,264,246   $9,599,366 

 

41

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

Note 7 – Fair Value of Financial Instruments

 

The Company evaluates its financial assets and liabilities subject to fair value measurements on a recurring basis to determine the appropriate level in which to classify them for each reporting period. This determination requires significant judgments to be made.

 

The Company did not have any financial assets and liabilities that were measured at fair value on a recurring basis at June 30, 2025 and December 31, 2024, respectively.

 

Note 8 – Commitments and Contingencies

 

Operating Leases

 

We have entered into various operating lease agreements, including our corporate headquarters. We account for leases in accordance with ASC Topic 842: Leases, which requires a lessee to utilize the right-of-use model and to record a right-of-use asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases are classified as either financing or operating, with classification affecting the pattern of expense recognition in the statement of operations. In addition, a lessor is required to classify leases as either sales-type, financing or operating. A lease will be treated as a sale if it transfers all of the risks and rewards, as well as control of the underlying asset, to the lessee. If risks and rewards are conveyed without the transfer of control, the lease is treated as financing. If the lessor does not convey risk and rewards or control, the lease is treated as operating. We determine if an arrangement is a lease, or contains a lease, at inception and record the lease in our financial statements upon lease commencement, which is the date when the underlying asset is made available for use by the lessor.

 

Right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments over the lease term. Lease right-of-use assets and liabilities at commencement are initially measured at the present value of lease payments over the lease term. We generally use our incremental borrowing rate based on the information available at commencement to determine the present value of lease payments except when an implicit interest rate is readily determinable. We determine our incremental borrowing rate based on market sources including relevant industry data.

 

We have lease agreements with lease and non-lease components and have elected to utilize the practical expedient to account for lease and non-lease components together as a single combined lease component, from both a lessee and lessor perspective with the exception of direct sales-type leases and production equipment classes embedded in supply agreements. From a lessor perspective, the timing and pattern of transfer are the same for the non-lease components and associated lease component and, the lease component, if accounted for separately, would be classified as an operating lease.

 

42

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

We have elected not to present short-term leases on the balance sheet as these leases have a lease term of 12 months or less at lease inception and do not contain purchase options or renewal terms that we are reasonably certain to exercise. All other lease assets and lease liabilities are recognized based on the present value of lease payments over the lease term at commencement date. Because most of our leases do not provide an implicit rate of return, we used our incremental borrowing rate based on the information available at lease commencement date in determining the present value of lease payments.

 

Our leases, where we are the lessee, do not include an option to extend the lease term. For purposes of calculating lease liabilities, lease term would include options to extend or terminate the lease when it is reasonably certain that we will exercise such options.

 

Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense, included as a component of general and administrative expenses, in the accompanying consolidated statements of operations.

 

Certain operating leases provide for annual increases to lease payments based on an index or rate, our lease has no stated increase, payments were fixed at lease inception. We calculate the present value of future lease payments based on the index or rate at the lease commencement date. Differences between the calculated lease payment and actual payment are expensed as incurred.

 

In 2024, in connection with our purchase of CLMI, we acquired a right-of-use operating lease and related lease liability for a building having a fair value of $98,638.

 

Year End December 31, 2024

 

Lease Termination and Loss on Right-of-Use Asset

 

Effective August 31, 2024, the Company entered into an agreement to terminate two (2) of its operating leases prior to the expiration of the lease term. The early termination resulted in the derecognition of these Right-of-Use (ROU) assets and the corresponding lease liabilities associated with these leases.

 

In connection with the termination, the Company made a buyout payment of $212,175 to the lessor to settle all remaining lease obligations.

 

The carrying amounts of the lease liability and ROU asset as of the termination date were as follows:

 

Right-of-Use Asset (ROU) carrying amount: $309,826
Lease Liability: $327,138

 

43

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

As a result of the termination, the Company recognized a loss of $194,863 which is reported in the Company’s consolidated statements of operations under the line item “Other expenses” for the years ended December 31, 2024.

 

The loss was calculated as follows:

 

      
ROU Asset   309,826 
Cash paid to execute lease termination   212,175 
ROU Liability   (327,138)
Loss on lease termination   194,863 

 

The termination of these leases resulted in the complete derecognition of these ROU assets and the corresponding lease liabilities. The Company does not expect any future obligations or payments related to these lease agreements following the settlement.

 

On October 1, 2024, the Company signed a lease for 2,293 square feet of office space in San Salvador. The lease term is 32 months, and expires May 2027, and the total monthly payment is $18,958, including base rent, estimated operating expenses and sales tax.

 

The lease is subject to a 3% annual increase. An initial Right of Use (“ROU”) asset of $565,650 will be recognized as a non-cash asset addition.

 

At June 30, 2025 and December 31, 2024, respectively, the Company had no financing leases as defined in ASC 842, “Leases.”

 

The tables below present information regarding the Company’s operating lease assets and liabilities at June 30, 2025 and December 31, 2024, respectively:

 

44

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

   June 30, 2025   December 31, 2024 
Assets          
           
Operating lease - right-of-use asset - non-current  $441,225   $564,781 
           
Liabilities          
           
Operating lease liability  $446,249   $567,301 
           
Weighted-average remaining lease term (years)   1.84    2.29 
           
Weighted-average discount rate   8%   8%

 

The components of lease expense were as follows:

 

 

   June 30, 2025   June 30, 2024 
   Six Months Ended 
   June 30, 2025   June 30, 2024 
         
Operating lease costs          
           
Amortization of right-of-use operating lease asset  $123,556   $46,995 
Lease liability expense in connection with obligation repayment   19,073    10,742 
Total operating lease costs  $142,629   $57,737 
           
Supplemental cash flow information related to operating leases was as follows:          
           
Operating cash outflows from operating lease (obligation payment)  $140,125   $56,134 
Right-of-use asset obtained in exchange for new operating lease liability  $-   $98,638 

 

45

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

Future minimum lease payments for the years ended December 31:

 

Year Ended December 31,    
2025 (6 months)  $141,831 
2026   236,078 
2027   100,563 
Total undiscounted cash flows   478,472 
Less: amount representing interest   32,223 
Present value of operating lease liabilities   446,249 
Less: current portion of operating lease liabilities   248,069 
Long-term operating lease liabilities  $198,180 

 

Employment Agreements (Chief Executive Officer and Chief Financial Officer)

 

Chief Financial Officer

 

In November 2023, the Company finalized the terms of its employment agreement with its Chief Financial Officer as follows:

 

1.Base salary

a.For the year ended December 31, 2023 - $475,000,

b.For the year ended December 31, 2024 - $489,250; and

c.For the year ended December 31, 2025 - $503,928

2.Annual cash bonus

a.For the year ended December 31, 2023 - $510,000,

b.For the year ended December 31, 2024 – at least $510,000; and

c.For the year ended December 31, 2025 - subject to Board approval

 

3.Restricted Stock Awards

a.Effective November 10, 2023, an award of 600,000 shares of common stock. The fair value of this grant was $3,114,000, based upon the quoted closing price of $5.19/share.

b.The shares will vest as follows (see below for table on non-vested shares):

i.400,000 shares ratably over the period July 2024 – December 2024 (66,667 shares per month over a six-month period); and

ii.200,000 on December 31, 2025,

iii.Shares shall immediately vest if any of the following occur and the Chief Financial Officer is employed by the Company at the time of:

1.Death,

2.Total disability,

3.Termination without cause; and

4.Change in control

 

46

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

4.Other

a.Vacation,
b.Car allowance of $500 per month; and
c.Home office expense reimbursement of $667 per month,
d.401(K) plan participation,
e.Life insurance; and
f.Liability insurance

 

See Note 9 regarding the vesting provisions of these shares.

 

Chief Executive Officer

 

In December 2023, the Company finalized the terms of its employment agreement with its Chief Executive Officer as follows:

 

1.Term – through December 31, 2028
2.Base salary

a.For the year ended December 31, 2023 - $750,000,
b.For each year thereafter an increase of 3%

3.Annual cash bonus

a.For the year ended December 31, 2023, and all other years throughout the term of the employment agreement - $870,000.

4.Restricted Stock Awards
  

On March 1, 2024, the Board approved a long-term equity program for the Company’s Chief Executive Officer providing for a maximum of 2,500,000 shares of common stock to be awarded over a five-year period, subject to annual Board approval. The program anticipates awards of 500,000 shares per year, with each award scheduled to be granted and vest on June 1 of the applicable year. In accordance with ASC 718-10-25-2 and ASC 718-10-55-108 through 55-110, the requirement for annual Board approval means that no grant date for future installments is established until such approval is obtained.

 

The initial award of 500,000 shares was granted on July 1, 2024, to vest ratably over the period July 2024 through December 2024 (83,333 shares per month). The fair value of this award, measured at the July 1, 2024 grant date, was $3,800,000, based on the closing market price of $7.60 per share.

 

The second award of 500,000 shares was approved on June 26, 2025, with a revised vesting date of December 31, 2025 (originally June 1, 2025). In subsequent years, additional 500,000 share awards are expected to be approved and granted on or around June 1 of 2026, 2027, and 2028. In accordance with SEC SAB Topic 14.D.2, the fair value of each award will be determined at its respective grant date based on the closing market price on that date.

 

Because each year’s installment is subject to separate Board approval, each represents a separate award under ASC 718. Consistent with ASC 718-10-55-87 through 55-88, the grant-date fair value for each installment will be measured when Board approval is obtained and recognized as compensation expense over the requisite service period applicable to that installment, which is expected to be grant date, as no future service is required.

 

Shares shall immediately vest if any of the following occur and the Chief Executive Officer is employed by the Company at the time of:

1.Death,
2.Total disability,
3.Termination without cause; and
4.Change in control

 

47

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

5.Annual Revenue Goals (only one (1) award per goal may be earned until next threshold is achieved

a.$250,000,000 – value of restricted stock award will be $6,250,000,
b.$500,000,000 – value of restricted stock award will be $25,000,000,
c.$1,000,000,000 – value of restricted stock award will be $50,000,000,
d.$2,000,000,000 – value of restricted tock award will be $100,000,000; and
e.Each additional $1,000,000,000 – value of restricted tock award will be $50,000,000,

 

6.Annual EBITDA Goals (only one (1) award per goal may be earned until next threshold is achieved

a.$50,000,000 - value of restricted stock award will be $2,500,000,
b.$100,000,000 - value of restricted stock award will be $5,000,000; and
c.Each additional $50,000,000 - value of restricted stock award will be $2,500,000

 

7.Market Capitalization Goals (only one (1) award per goal may be earned until next threshold is achieved

a.$250,000,000 - value of restricted stock award will be $25,000,000,
b.$500,000,000 - value of restricted stock award will be $50,000,000,
c.$1,000,000,000 - value of restricted stock award will be $100,000,000,
d.$2,000,000,000 - value of restricted stock award will be $200,000,000; and
e.Each additional $1,000,000,000 - value of restricted stock award will be $100,000,000

 

8.Other

a.Vacation,
b.Car allowance of $500 per month; and
c.Home office expense reimbursement of $667 per month,
d.401(K) plan participation,
e.Life insurance; and
f.Liability insurance

 

See Note 9 regarding the vesting provisions of these shares.

 

48

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

Contingencies – Legal Matters

 

In the normal course of business, the Company may be subject to litigation, claims, and legal proceedings. The Company evaluates legal contingencies in accordance with FASB ASC 450-20-50, “Contingencies”, which requires recognition of a liability if an unfavorable outcome is both probable and can be reasonably estimated.

 

When a legal matter arises, the Company:

 

Assesses the merits of the case, including available defenses.
Evaluates its potential exposure and possible legal or settlement strategies.
Determines the likelihood of an unfavorable outcome based on available information.
Establishes an accrual if a loss is both probable and reasonably estimable.

 

As of June 30, 2025, based on management’s review and consultation with legal counsel, the Company is not aware of any contingent liabilities that require accrual or disclosure in the consolidated financial statements.

 

Surge Holdings – Juno Litigation

 

Juno Financial v. AATAC and Surge Holdings Inc. and Surge Holdings Inc. v. AATAC; Circuit Court of Hillsborough County, Florida, Case # 20-CA-2712 DIV A: Breach of Contract, Account Stated and Open Account claims against Surge by a factoring company. Surge has filed a cross-complaint against defendant AATAC for Breach of Contract, Account Stated, Open Account and Common Law Indemnity. The Court dismissed the case with the agreement of the parties at a case management conference on September 12, 2024.

 

True Wireless and SurgePays – Litigation

 

Blue Skies Connections, LLC, and True Wireless, Inc. v. SurgePays, Inc., et. al.: In the District Court of Oklahoma County, OK, CJ-2021-5327, filed on December 13, 2021. Plaintiffs’ petition alleges breach of a Stock Purchase Agreement by SurgePays, SurgePhone Wireless, LLC, and Kevin Brian Cox (“Defendants”), and makes other allegations related to SurgePays’ consulting work with Jonathan Coffman, formerly a True Wireless employee. The petition requests injunctive relief, general damages, punitive damages, attorney fees and costs for alleged breach of contract, tortious interference with a business relationship, and fraud. Blue Skies alleged the Defendants are in violation of their non-competition and non-solicitation agreements related to the sale of True Wireless from SurgePays to Blue Skies. Defendants filed various dispositive motions with the Court demonstrating Oklahoma state law does not recognize non-compete agreements and non-solicitation agreements in the manner alleged by Plaintiffs, and the Court granted these motions, finding the non-solicitation and non-competition clauses in the Stock Purchase Agreement void as a matter of Oklahoma law. Defendants then filed additional dispositive motions on Plaintiffs’ claims in tort and equity, which the Court granted in part based on its prior rulings. Plaintiffs took the position the Court granting Defendants’ dispositive motions on these material issues only leaves partial contract claims that are inextricably intertwined with the remaining claims and defenses. Plaintiffs sought a certified interlocutory appeal of the Court’s orders. On March 10, 2025, the Oklahoma Supreme Court entered an order denying Plaintiffs’ Petition for Certiorari to review the certified interlocutory appeal. The case will now proceed in the district court on the parties’ remaining claims. Both parties have filed motions for summary judgment on the remaining claims, which will be decided in Fall of 2025. Presently, there is no trial date. An attempt at mediation in July 2022 did not achieve a settlement. Any further settlement discussions will occur in the context of Defendants having prevailed on the majority of Plaintiffs’ claims.

 

49

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

In the Circuit Court of Tennessee for the 30th Judicial District at Memphis, Docket # CT-3219-23. On August 8, 2023, a complaint was filed by SurgePays for breach of a promissory note by Blue Skies Connections, LLC. The note at issue is dated June 14, 2021, and requires Blue Skies Connections to repay the principal sum of $176,850.56, by monthly payments of $7,461.37 commencing on June 1, 2023. Blue Skies Connections has failed to make any payments due under the terms of the note, and this breach entitles SurgePays to demand payment of the entire amount of the note together with all accrued interest. Blue Skies Connections responded by filing a Motion to Dismiss or, in the alternative, a Motion to Stay, taking the position that, under the prior suit pending doctrine, the subject promissory note is subject to the prior litigation instituted by Blue Skies Connections against SurgePays, styled Skies Connections, LLC and True Wireless, Inc. v. SurgePays, Inc., et al., Case No. CJ-2021-5327, District Court of Oklahoma County, Oklahoma. Surge Pays elected to dismiss its complaint without prejudice and of re-filed the matter in the District Court of Oklahoma County, Oklahoma at Case No. CJ-2025-810. The matter is in the early stages of discovery.

 

Mike Fina - Litigation

 

SurgePays, Inc. et al. v. Fina et al., Case No. CJ-2022-2782, District Court of Oklahoma County, Oklahoma. Plaintiffs SurgePays, Inc. and Kevin Brian Cox initiated this case against its former officer Mike Fina, his companies Blue Skies Connections, LLC, True Wireless, Inc., Government Consulting Solutions, Inc., Mussell Communications LLC, and others. This case also arises from the June 2021 transaction by which SurgePays sold True Wireless to Blue Skies. During the litigation of CJ-2021-5327 described above, SurgePays learned information that showed Mike Fina breached his duties owed to True Wireless during his employment and consulting work for True Wireless prior to SurgePays’ sale of True Wireless to Blue Skies. SurgePays alleges that Mike Fina conspired with the other defendants to damage True Wireless thereby harming the value of the company and causing its eventual sale at a greatly reduced price. SurgePays asserts claims for (i) breach of contract; (ii) breach of fiduciary duty; (iii) fraud; (iv) tortious interference; and (v) unjust enrichment. At this stage, no defendant has asserted a counterclaim against SurgePays. SurgePays filed a Second Amended Petition on January 27, 2023. Defendants Fina, Blue Skies, True Wireless, and Government Consulting Solutions filed a Motion to Dismiss on March 10, 2023. On June 29, 2023, the Court granted the Motion to Dismiss, ruling the claims asserted are “derivative” and could only be asserted by the True Wireless entity now owed by Blue Skies. The Court rejected SurgePays’ request to certify this ruling for immediate appeal. Defendant Misty Garrett filed a Motion for Summary Judgment seeking the same relief as the Motion to Dismiss, which was granted by the Court.

 

All claims against all parties have been adjudicated by the Court. SurgePays filed a Motion for New Trial, which was denied by the Court on February 20, 2025.  SurgePays’ has filed an appeal of the Court’s dismissal of Fina, Blue Skies, True Wireless, Government Consulting Solutions, and summary judgment for Misty Garrett. At this stage, no attempts at settlement have been made.

 

50

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

Note 9 – Stockholders’ Equity

 

At June 30, 2025, the Company had three (3) classes of stock:

 

Common Stock

 

-500,000,000 shares authorized
-Par value - $0.001
-Voting at 1 vote per share

 

Series A, Convertible Preferred Stock

 

-13,000,000 shares authorized
-None issued and outstanding
-Par value - $0.001

-Voting at 10 votes per share

-Ranks senior to any other class of preferred stock
-Dividends - none
-Liquidation preference – none
-Rights of redemption - none
-Conversion into 1/10 of a share of common stock for each share held

 

Series C, Convertible Preferred Stock

 

-1,000,000 shares authorized
-None issued and outstanding
-Par value - $0.001
-Voting at 250 votes per share
-Ranks junior to any other class of preferred stock
-Dividends – equal to the per share amount (as converted basis) as the common stockholders should the Board of Directors declare a dividend
-Liquidation preference – original issue price plus any declared yet unpaid accrued dividends
-Rights of redemption - none
-Conversion into 250 shares of common stock for each share held

 

Securities and Incentive Plan

 

In March 2023, the Company’s shareholders approved the 2022 Plan (the “Plan”) initially approved, authorized and adopted by the Board of Directors in August 2022.

 

The Plan initially provided for the following:

 

1.3,500,000 shares of common stock

2.An annual increase on the first day of each calendar year beginning January 1, 2023 and ending on January 31, 2031 equal to the lesser of:

a.10% of the common stock outstanding on the final day of the immediately preceding calendar year, or
b.Such smaller amount of common stock as determined by the Board of Directors.

3.The shares may be issued as follows to directors, officers, employees, and consultants:

a.Distribution equivalent rights
b.Incentive share options
c.Non-qualified share options
d.Performance unit awards

 

51

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

e.Restricted share awards
f.Restricted share unit awards
g.Share appreciation rights
h.Tandem share appreciation rights
i.Unrestricted share awards

 

See the proxy statement filed with the SEC on January 19, 2023 for a complete detail of the Plan.

 

Effective January 1, 2024, in accordance with the Plan, we increased the available amount of shares by 10% of the common stock outstanding on December 31, 2023, approximating an additional 1,400,000 shares of common stock. After this increase, total shares authorized and available to be issued under the Plan approximated 4,900,000 shares.

 

Effective January 1, 2025, in accordance with the Plan, we increased the available amount of shares by 10% of the common stock outstanding on December 31, 2024, approximating an additional 2,007,000 shares of common stock. After this increase, total shares authorized and available to be issued under the Plan approximated 6,907,000 shares.

 

Of the total shares authorized and available, the Company has reserved shares for its officers, directors and employees for non-vested shares that are expected to vest in accordance with the terms of the related employment agreements and stock options that may be converted into common stock. At June 30, 2025, the Company had sufficient authorized shares to settle any possible awards that vested or stock options eligible for conversion.

 

Equity Transactions for the Six Months Ended June 30, 2025

 

Treasury Stock

 

The Company repurchased 333,333 shares of its common stock from a convertible note payable holder for $999,999 ($3/share). In connection with the transaction, the principal balance of the related convertible note was increased by $999,999. See Note 5.

 

Equity Transactions for the Years Ended December 31, 2024

 

Stock Issued for Cash - Capital Raise

 

The Company issued 3,080,356 shares of common stock for gross proceeds of $17,249,994 ($5.60/share).

 

In connection with the capital raise, the Company paid cash as direct offering costs totaling $1,395,000, resulting in net proceeds of $15,854,994.

 

52

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

This offering was made pursuant to the Company’s registration statement on Form S-3 (File No. 333-273110) previously filed with the Securities and Exchange Commission (the “SEC”) on July 3, 2023, as amended, and declared effective by the SEC on November 3, 2023.

 

A preliminary and final prospectus supplement were filed with the Securities and Exchange Commission pursuant to Rule 424(b) under the Securities Act of 1933 (the “Securities Act”) on January 17, 2024 and January 19, 2024, respectively. The Offering closed on January 22, 2024.

 

Exercise of Warrants - Cash

 

During 2024, the Company issued 1,860,308 shares of common stock in connection with the exercise of 1,860,308 warrants for $8,799,257 ($4.73/share). See warrant table below.

 

Exercise of Warrants - Cashless

 

During 2024, the Company issued 40,238 shares of common stock in connection with the cashless exercise of warrants ($0.001/share). The transaction had a net effect of $0 on stockholders’ equity. See warrant table below.

 

Stock Issued for Services

 

The Company issued 47,386 shares of common stock for services rendered, having a fair value of $411,740 ($3.85 - $7.34/share), based upon the quoted closing trading price.

 

See separate discussion below for the issuance and related vesting of common stock granted to the Company’s officers and directors.

 

Treasury Stock

 

Effective July 2024, the Company implemented a share repurchase program. Under the terms of this program, the Company undertook the following:

 

Maximum dollar amount authorized for repurchase is $5,000,000,
The Company will not repurchase more than 20,000 shares per day,
The Company will not repurchase any shares greater than $5/share,
Share repurchases will only be made to the extent it does not prevent the Company from paying its debts; and
The shares may either be returned to the treasury and authorized for reissuance or cancelled and retired.

 

The Company reacquired 362,620 shares of treasury stock for $631,967, at an average price of $1.74/share.

 

53

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

Effective October 2024, the Company ceased its share repurchase program.

 

Non-Vested Shares – Related Parties (Officer and Directors) – and related Vesting

 

Chief Financial Officer

 

In 2023, the Company granted common stock to its Chief Financial Officer (600,000 shares – see Note 8), having a fair value of $3,114,000 ($5.19/share), based upon the quoted closing trading price.

 

The shares will vest as noted above (see Note 8). The Company records stock compensation expense ratably over these vesting periods. All shares are expected to vest in accordance with the terms of the agreement.

 

For the three months ended June 30, 2025 and 2024, the Company recognized stock compensation expense of $119,769 and $729,363, respectively, related to vesting.

 

For the six months ended June 30, 2025 and 2024, the Company recognized stock compensation expense of $239,538 and $1,458,725, respectively, related to vesting.

 

Board Directors

 

2025 Grant

 

In 2025, the Company granted an aggregate 150,000 shares of common stock to various members of the Board of Directors, having a fair value of $474,000 ($3.16/share), based upon the quoted closing trading price.

 

The shares will vest at the earlier to occur:

 

  - Board Member no longer serves in that capacity for any reason, except for reasons related to cause,
  - Occurrence of a change in control; and
  - August 2028

 

2024 Grant

 

In 2024, the Company granted an aggregate 44,640 shares of common stock to various members of the Board of Directors, having a fair value of $149,990 ($3.36/share), based upon the quoted closing trading price.

 

The shares will vest at the earlier to occur:

 

-Board Member no longer serves in that capacity for any reason, except for reasons related to cause,
-Occurrence of a change in control; and
-4th anniversary of the effective date (2028)

 

54

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

The Company records stock compensation expense over the vesting period. All shares are expected to vest in accordance with the terms of the employment agreement.

 

For the three months ended June 30, 2025 and 2024, the Company recognized stock compensation expense of $35,350 and $25,975, respectively, related to vesting.

 

For the six months ended June 30, 2025 and 2024, the Company recognized stock compensation expense of $70,700 and $61,324, respectively, related to vesting.

 

Chief Executive Officer

 

In 2024, the Company granted common stock to its Chief Executive Officer (500,000 shares – see Note 8), having a fair value of $3,800,000 ($7.60/share), based upon the quoted closing trading price.

 

The shares will vest as noted above (see Note 8). The Company records stock compensation expense ratably over these vesting periods. All shares are expected to vest in accordance with the terms of the agreement.

 

For the three months ended June 30, 2025 and 2024, the Company recognized stock compensation expense of $0 and $1,891,704, respectively, related to vesting.

 

For the six months ended June 30, 2025 and 2024, the Company recognized stock compensation expense of $0 and $2,522,272, respectively, related to vesting.

 

Director of Human Resources and Legal Services

 

In 2024, the Company granted 100,000 shares of common stock to its Director of Human Resources and Legal Services, having a fair value of $672,000 ($6.72/share), based upon the quoted closing trading price.

 

The shares will vest ratably over the period July 2024 – December 2024. The Company records stock compensation expense ratably over these vesting periods. All shares are expected to vest in accordance with the terms of the agreement.

 

For the three months ended March 31, 2024, the Company recognized stock compensation expense of $111,511, related to vesting.

 

55

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

For the six months ended June 30, 2024, the Company recognized stock compensation expense of $446,047, related to vesting.

 

Total Compensation Expense due to Vesting

 

For the three months ended June 30, 2025 and 2024, the Company recognized total stock compensation expense of $155,119 and $2,981,577, related to all arrangements with vesting.

 

For the six months ended June 30, 2025 and 2024, the Company recognized total stock compensation expense of $310,238 and $4,478,994, related to all arrangements with vesting.

 

The following is a summary of the Company’s non-vested shares at June 30, 2025 and December 31, 2024.

 

       Weighted Average 
Non-Vested Shares  Number of Shares   Grant Date Fair Value 
Balance - December 31, 2023   695,000   $5.24 
Granted   644,640    7.60 
Vested   (1,000,000)   6.55 
Cancelled/Forfeited   -    - 
Balance - December 31, 2024  339,640    5.03 
Granted   150,000    3.16 
Vested   -    - 
Cancelled/Forfeited   -    - 
Balance - June 30, 2025   489,640   $4.46 
           
Unrecognized Compensation  $1,112,708      
           
Weighted average period (years)   1.64      

 

56

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

The following is a detail of the common stock granted, which is subject to the vesting provisions noted above at June 30, 2025 and December 31, 2024, respectively.

 

 

   CEO   CFO   Directors   Director of Human Resources/Legal   Total 
Balance - December 31, 2023   -    600,000    95,000    -    695,000 
Granted   500,000    -    44,640                       100,000    644,640 
Vested   (500,000)   (400,000)   -    (100,000)   (1,000,000)
Cancelled/Forfeited   -    -    -    -    - 
Balance - December 31, 2024   -    200,000    139,640    -    339,640 
Granted   -    -    

150,000

    -    150,000 
Vested   -    -    -    -    - 
Cancelled/Forfeited   -    -    -    -    - 
Balance - June 30, 2025   -    200,000    289,640    -    489,640 
                          
Unrecognized Compensation  $-   $239,538   $873,170   $-   $1,112,708 
                          
Weighted average period (years)   -    0.50    1.14    -    1.64 

 

Stock Options

 

Stock option transactions for the six months ended June 30, 2025 and the year ended December 31, 2024 are summarized as follows:

 

           Weighted       Weighted 
           Average       Average 
       Weighted   Remaining   Aggregate   Grant 
   Number of   Average   Contractual   Intrinsic   Date 
Stock Options  Options   Exercise Price   Term (Years)   Value   Fair Value 
Outstanding - December 31, 2023   121,276   $                  7.79                    6.47   $-          
Vested and Exercisable - December 31, 2023   116,174   $7.43    6.61   $-      
Unvested and non-exercisable - December 31, 2023   5,101   $16.00    3.16   $-      
Granted   1,054,603   $1.78                
Exercised   -   $-                
Cancelled/Forfeited   (9,798)  $6.45                
Outstanding - December 31, 2024   1,166,081   $2.37    6.85   $-      
Vested and Exercisable - December 31, 2024   1,166,081   $2.37    6.85   $-      
Unvested and non-exercisable - December 31, 2024   -   $-    -   $-      
Granted   -   $-                
Exercised   -   $-                
Cancelled/Forfeited   -   $-                
Outstanding - June 30, 2025   1,166,081   $2.37    6.36   $1,402,622      
Vested and Exercisable - June 30, 2025   1,166,081   $2.37    6.36   $1,402,622      
Unvested and non-exercisable - June 30, 2025   -   $-    -   $-      

 

Six Months Ended June 30, 2025

 

No activity.

 

Years Ended December 31, 2024

 

Stock Options - Related Party – Chief Financial Officer

 

The remaining 5,101 stock options vested, and the related expense was $6,196.

 

57

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

Stock Options – Chief Executive Officer, Chief Financial Officer and Employees

 

The Company granted an aggregate of 1,054,603, fully vested, seven (7) year stock options to the Company’s Chief Executive Officer (248,424), Chief Financial Officer (157,335) and various employees (648,844) for services rendered, having a fair value of $1,602,997. Of the total expense recognized, $616,754 related to the officers, and $986,243 related to the employees. These options have an exercise price of $1.78 per share.

 

The fair value of these stock options was determined using a Black-Scholes option pricing model with the following inputs:

 

Expected term   7 years 
Expected volatility   106%
Expected dividends   0%
Risk free interest rate   3.88%

 

Stock-based compensation expense for the three and six months ended June 30, 2025 and 2024 was as follows:

 

Three months ended June 30,   Six months ended June 30, 
2025   2024   2025   2024 
$-   $-   $-   $6,196 

 

Warrants

 

Warrant activity for the six months ended June 30, 2025 and the year ended December 31, 2024 are summarized as follows:

 

           Weighted     
           Average     
       Weighted   Remaining   Aggregate 
   Number of   Average   Contractual   Intrinsic 
Warrants  Warrants   Exercise Price   Term (Years)   Value 
Outstanding - December 31, 2023   5,574,253   $4.81    0.86   $9,348,348 
Vested and Exercisable - December 31, 2023   5,574,253   $4.81    0.86   $9,348,348 
Unvested - December 31, 2023   -   $-    -   $- 
Granted   -   $-           
Exercised   (1,953,308)  $4.73           
Cancelled/Forfeited   (3,524,945)  $4.86           
Outstanding - December 31, 2024   96,000   $4.73    0.37   $- 
Vested and Exercisable - December 31, 2024   96,000   $4.73    0.37   $- 
Unvested and non-exercisable - December 31, 2024   -   $-    -   $- 
Granted   700,000   $6.00           
Exercised   -   $-           
Cancelled/Forfeited   (93,000)  $4.73           
Outstanding - June 30, 2025   703,000   $5.99    4.85   $- 
Vested and Exercisable - June 30, 2025   703,000   $5.99    4.85   $- 
Unvested and non-exercisable - June 30, 2025   -   $-    -   $- 

 

See Note 6 regarding convertible note payable issued with 700,000 warrants.

 

Note 10 – Segment Information

 

Operating segments are defined as components of an enterprise about which separate financial information is available and evaluated regularly by the chief operating decision maker, or decision–making group, in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision maker is its Chief Executive Officer.

 

The Company evaluated the performance of its operating segments based on revenue and operating loss. All data below is prior to intercompany eliminations.

 

58

 

 

SURGEPAYS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2025

 

Segment information for the Company’s operations for the three and six months ended June 30, 2025 and 2024, are as follows:

 

   2025   2024   2025   2024 
   For the Three Months Ended June 30,   For the Six Months Ended June 30, 
   2025   2024   2025   2024 
                 
Revenues                    
Mobile Virtual Network Operators  $2,273,706   $12,503,507   $4,559,530   $41,396,096 
Point-of-Sale and Prepaid Services   9,244,460    2,576,820    17,536,066    5,107,409 
Other Corporate Overhead   -    5,372    -    11,329 
Total  $11,518,166   $15,085,699   $22,095,596   $46,514,834 
                     
Cost of revenues                    
Mobile Virtual Network Operators  $4,383,538   $16,013,697   $9,573,155   $36,773,896 
Point-of-Sale and Prepaid Services   9,788,813    2,509,116    18,118,971    4,990,922 
Other Corporate Overhead   481    5,961    481    10,425 
Total  $14,172,832   $18,528,774   $27,692,607   $41,775,243 
                     
Operating expenses                    
Mobile Virtual Network Operators  $285,526   $34,548   $881,752   $69,379 
Point-of-Sale and Prepaid Services   658,727    779,225    1,565,723    1,498,590 
Other Corporate Overhead   3,211,590    6,619,205    6,345,926    12,295,814 
Total  $4,155,843   $7,432,978   $8,793,401   $13,863,783 
                     
Income (loss) from operations                    
Mobile Virtual Network Operators  $(2,395,358)  $(3,544,738)  $(5,895,378)  $4,552,821 
Point-of-Sale and Prepaid Services   (1,203,081)   (711,521)   (2,148,108)   (1,382,103)
Other Corporate Overhead   (3,212,070)   (6,619,794)   (6,346,926)   (12,294,910)
Total  $(6,810,509)  $(10,876,053)  $(14,390,412)  $(9,124,192)

 

Segment information for the Company’s assets and liabilities at June 30, 2025 and December 31, 2024, are as follows:

 

   June 30, 2025   December 31, 2024 
         
Total Assets          
Mobile Virtual Network Operators  $5,690,101   $8,472,349 
Point-of-Sale and Prepaid Services   5,040,231    4,884,817 
Other Corporate Overhead   4,485,077    10,618,839 
Total  $15,215,409   $23,976,005 
           
Total Liabilities          
Mobile Virtual Network Operators  $1,835,032   $1,505,400 
Point-of-Sale and Prepaid Services   696,235    103,612 
Other Corporate Overhead   12,622,750    7,105,380 
Total  $15,154,017   $8,714,392 

 

All intercompany accounts are separately presented above as both a component of the assets and liabilities. These amounts net to $0 in the Company’s consolidated balance sheets.

 

Note 11 – Subsequent Event

 

At the Market Offering - Financing

 

In August 2025, the Company entered into an At The Market Offering Agreement (the “ATM Agreement”) with Titan Partners Group LLC, a division of American Capital Partners, LLC (“Titan”), pursuant to which the Company may, from time to time, offer and sell shares of its common stock (subject to certain limitations in the ATM Agreement) to or through Titan, acting as sales agent and/or principal. Under the Prospectus Supplement, the Company may offer and sell shares of its common stock having an aggregate offering price of up to $15,000,000, which is within the Company’s current “baby shelf” limitations under General Instruction I.B.6. of Form S-3. The Company intends to utilize the ATM Agreement, when appropriate, to fund working capital needs on an ongoing basis.

 

59

 

 

ITEM 2: MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

This statement contains forward-looking statements within the meaning of the Securities Act of 1933, as amended (the ‘Securities Act’). Discussions containing such forward-looking statements may be found throughout this statement. Actual events or results may differ materially from those discussed in the forward-looking statements as a result of various factors, including the matters set forth in this statement. The accompanying consolidated financial statements as of June 30, 2025 and 2024 and for the three and six months then ended includes the accounts of SurgePays, Inc. and its wholly owned subsidiaries during the period owned by SurgePays, Inc.

 

About SurgePays, Inc.

 

SurgePays, Inc (“SurgePays,” “we” the “Company”) was incorporated in Nevada on August 18, 2006 is a financial technology and telecom company focused on providing these essential services to the underbanked community. We were previously known as North American Energy Resources, Inc. and KSIX Media Holdings, Inc. Prior to April 27, 2015, we operated solely as an independent oil and natural gas company engaged in the acquisition, exploration and development of oil and natural gas properties and the production of oil and natural gas through its wholly owned subsidiary, NAER. On April 27, 2015, NAER entered into a Share Exchange Agreement with KSIX Media whereby KSIX Media became a wholly owned subsidiary of NAER and which resulted in the shareholders of KSIX Media owning approximately 90% of the voting stock of the surviving entity. While we continued the oil and gas operations of NAER following this transaction, on August 4, 2015, we changed its name to KSIX Media Holdings, Inc. On December 21, 2017, we changed its name to Surge Holdings, Inc. to better reflect the diversity of its business operations. We changed our name to SurgePays, Inc. on October 29, 2020.

 

As described in more detail below, we currently operate in two different business segments through the following subsidiaries: (i) SurgePhone Wireless, LLC, a Nevada limited liability company; (ii) SurgePays Fintech, Inc., a Nevada limited liability company; (iii) ECS Prepaid, LLC, a Missouri limited liability company and (iv) Torch Wireless a Wyoming limited liability company.

 

60

 

 

Our Business Segments

 

SurgePays operates through two primary business segments, each strategically designed to meet the diverse needs of our customers. These segments are driven by independent technology platforms that also function synergistically to foster mutual growth:

 

  MVNO Wireless Services: Providing reliable, affordable prepaid wireless services.
     
  Point-of-Sale and Prepaid Services: Offering Point-of-sale (“POS”) transaction and marketing technology.

 

In addition, in November 2024, the Company entered into a multi-year strategic agreement with AT&T, providing direct access to its nationwide 4G LTE and 5G wireless network. This integration represents a significant advancement in the Company’s infrastructure and capabilities, enabling SurgePays to operate not only as a Mobile Virtual Network Operator (MVNO), but also as a Mobile Virtual Network Enabler (MVNE). As an MVNE, the Company now offers wireless services, including SIM provisioning, billing, and airtime, to other wireless providers that do not have a direct carrier relationship. This expansion creates a new high-margin, scalable revenue channel with minimal incremental cost to the Company, and anticipate this to become another major segment for the Company starting in 2025.

 

The Company previously also operated a Lead Generation segment; however, this business segment was discontinued in 2024.

 

MVNO Wireless Services

 

SurgePays’ Mobile Virtual Network Operator (MVNO) business delivers high-speed, reliable, and affordable wireless services by leveraging agreements with national telecom leaders. Generating $43,450,244 of year ended December 31, 2024 operating revenue, we believe this segment will be central to our growth, offering subsidized and prepaid options to meet diverse financial needs.

 

Mobile Wireless Services:

 

● LinkUp Mobile: A prepaid wireless offering targeting customers seeking affordable, no-contract plans with nationwide coverage, including U.S., Mexico, and Canada roaming. SurgePays sells low-cost SIM kits and devices through a retail distribution network of over 9,000 convenience stores and online channels.

 

● Torch Wireless: A subsidized Lifeline brand serving low-income consumers across eligible states. SurgePays offers federally supported wireless service under the Lifeline program, which provides a monthly reimbursement per qualifying subscriber. In California, the combined federal and state support results in one of the most attractive reimbursement rates nationally ($28.25/subscriber).

 

SurgePays’ MVNO subscriber acquisition strategy includes both in-store and online enrollments, often facilitated through third-party enrollment partners and supported by in-house systems to streamline customer onboarding and device activation.

 

MVNE Platform – HERO

 

In late 2024, SurgePays launched its HERO platform, a full-stack mobile virtual network enabler (MVNE) system designed to support the launch and management of independent MVNOs. Through a strategic agreement with AT&T, the Company gained direct access to 4G LTE and 5G networks, enabling HERO to provide:

 

● SIM provisioning and activation

 

● Billing, CRM, and subscriber management tools

 

● Bilingual customer service

 

● White-labeled infrastructure for third-party brands

 

● Option fulfillment, logistics, and device procurement

 

HERO operates on a scalable per-click revenue model and supports both traditional and subsidized wireless offerings. MVNO clients benefit from HERO’s turnkey, infrastructure-free deployment and rapid go-to-market capabilities. With multiple MVNOs launched and additional partners onboarding in 2025, the Company anticipates this platform will become a major contributor to high-margin, recurring revenue.

 

61

 

 

Point-of-Sale and Prepaid Services

 

SurgePays’ retail-facing segment includes prepaid top-ups, POS transaction software, and in-store marketing technology:

 

● Prepaid Wireless Top-Ups: SurgePays provides convenience store clerks with the ability to process top-ups across major wireless brands, handle debit/gift card activations, and facilitate bill payments. These high-frequency transactions generate recurring revenue and support customer cross-selling opportunities, such as upselling LinkUp wireless.

 

● ClearLine POS Technology: ClearLine is a patent-pending SaaS application that transforms existing POS terminals and screens into interactive marketing and loyalty tools. It displays QR codes, digital promotions, real-time couponing, and captures analytics to enhance merchant engagement. ClearLine integrates with major terminal providers including Clover, PAX, and Landi.

 

By embedding fintech services into local store ecosystems, SurgePays creates a powerful customer acquisition and data feedback loop. The Company’s retail software is compatible with thousands of independent merchant locations, positioning it to grow with minimal hardware friction.

 

Growth Strategies

 

At SurgePays, our growth strategy is simple yet powerful: leverage our strengths across business segments to drive for sustainable, scalable growth. Each business unit and service is aligned with our mission to create lasting value, enabling us to be strategically positioned for our goal of long-term profitability.

 

Our current growth initiatives include:

 

● Scaling Lifeline enrollments in California and other high-subsidy states

 

● Expanding prepaid retail distribution across rural and multicultural markets

 

● Enabling wireless service launches for non-telecom brands through HERO

 

● Increasing ClearLine deployments and upselling POS features to merchants

 

62

 

 

Synergy Across Business Units

 

Our integrated approach means all units work in unison, creating efficiency and value that is hard to replicate. By aligning technology, data, and market expansion strategies, we are building a cohesive platform with a unique value proposition:

 

  Technology Integration: Our POS platforms unify transactions across prepaid wireless, financial products, and merchant services, delivering a streamlined retail experience.
  Data-Driven Engagement: Data analytics from our ACH banking and fintech transactions platform unlock valuable insights, enhancing customer engagement across all segments.
  Strategic Market Expansion: With a focus on underserved and rural markets, we are capturing untapped potential and fostering lasting customer loyalty.

 

COMPARISON OF THREE MONTHS ENDED June 30, 2025 AND 2024

 

Reclassifications

 

Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the consolidated results of operations, stockholders’ deficit, or cash flows.

 

We measure our performance on a consolidated basis as well as the performance of each segment.

 

We report our financial performance based on the following segments: Mobile Virtual Network Operators (MVNO), and Point-of-Sale and Prepaid Services (Top-up). The MVNO segment includes subsidized (Lifeline) and non-subsidized components (LinkUp Mobile). The subsidized component or Lifeline is the result of the mobile broadband (phone and internet) services provided by Torch Wireless to eligible consumers. The Point-of-Sale and Prepaid Services segment is comprised of Surge Fintech and ECS as previously shown.

 

The segment amounts included in MD&A are presented on a basis consistent with our internal management reporting. Additional information on our reportable segments is contained in Note 10 – Segment Information and Geographic Data of the Notes to Financial Statements.

 

Revenues during the three months ended years ended June 30, 2025 and 2024 consisted of the following:

 

   2025   2024 
Revenue  $11,518,166   $15,085,699 
Cost of revenue (exclusive of depreciation and amortization)   (14,172,832)   (18,528,774)
General and administrative   (4,155,843)   (7,432,978)
Income (Loss) from operations  $(6,810,509)  $(10,876,053)

 

63

 

 

Revenue decreased overall by $3,567,533 (23.7%) from the three months ended June 30, 2024 to the three months ended June 30, 2025. The breakout was as follows:

 

   For the Three Months Ended June 30, 
   2025   2024 
         
Revenues:          
Mobile Virtual Network Operator  $2,273,706   $12,503,507 
Point-of-Sale and Prepaid Services   9,244,460    2,576,820 
Other Corporate Overhead   -    5,372 
Total  $11,518,166   $15,085,699 

 

Mobile Virtual Network Operators consisting of SurgePhone Wireless and Torch Wireless revenues (as detailed in Notes 2 and 10 of the financial statements) decreased by $10,229,801 (81.8%). Due to a lack of additional funding from Congress, April 2024 was the last month ACP households received the full ACP discount, as they had received in prior months, and effective June 1, 2024, households no longer receive an ACP discount.

 

The Company signed a Master Services Agreement (MSA) with TerraCom, Inc. (“TerraCom”), a wireless service provider and licensed Lifeline provider, effective October 3, 2024, in order to execute the strategy of offering Lifeline to our existing ACP subscriber base. This agreement allowed us to offer a government-subsidized program to our previous 250,000 ACP wireless subscribers. We transitioned over 80,000 subscribers to the Lifeline program during 2024. Equally important, this allows us to reignite our sales channels to acquire new Lifeline subscribers who lost their ACP service when their carrier chose to shut them off.

 

Point-of-Sale and Prepaid Services (Prepaid) revenues increased by $6,667,640 or 258.8% as a result of increasing our sales force and hiring of a new Director of Sales and renewed focus on this segment of the business. The Company expects this segment to continue to grow for the remainder of 2025.

 

Effective December 31, 2024, the Company’s management elected to abandon its lead generation segment operations as part of a strategic reassessment of its business lines. This decision followed a review by the Chief Operating Decision Maker (“CODM”, which is our Chief Executive Officer), who had been regularly evaluating the segment’s financial performance and determined that its continued operation was no longer aligned with the Company’s long-term strategic objectives. The revenue was $0 and $0 respectively in the year ended December 31, 2024 and in the six months ended June 30, 2025 Comparison numbers for the lead generation segment are shown in the respective Other Corporate Overhead lines.

 

64

 

 

Cost of Revenue, Gross Profit and Gross Margin

 

For the three months ended June 30, 2025, cost of revenue for services primarily consists of data plan expenses ($1,931,585), prepaid retail expenses ($9,788,814), devices ($481,737), marketing ($368,647), advertising ($331,000) and other expenses such as royalties and call-center expenses ($1,271,049). For the three months ended June 30, 2024, cost of revenue for services primarily consists of data plan expenses ($9,011,476), devices ($1,145.609), marketing ($5,763,093), advertising ($1,377,794) and other expenses such as royalties and call-center expenses ($1,230,802).

 

We expect that our cost of revenue will increase or decrease to the extent that our revenue increases and decreases.

 

   For the Three Months Ended June 30, 
   2025   2024 
Cost of Revenue (exclusive of depreciation and amortization):          
Mobile Virtual Network Operator  $4,383,538   $16,013,697 
Point-of-Sale and Prepaid Services   9,789,295    2,509,116 
Other Corporate Overhead   -    5,961 
Total  $14,172,832   $18,528,774 

 

Gross profit margin is calculated as revenue less cost of revenue. Gross profit margin is gross profit expressed as a percentage of revenue. Our gross profit in future periods will depend on a variety of factors, including market conditions that may impact our pricing, sales mix among devices, sales mix changes among consumables, excess and obsolete inventories, and the cost of our products from manufacturers. Our gross profit in future periods will vary based upon our revenue stream mix and may increase based upon our distribution channels

 

   For the Three Months Ended June 30, 
   2025   2024 
         
Gross Profit (Loss) (exclusive of depreciation and amortization):          
Mobile Virtual Network Operator  $(2,109,831)  $(3,510,190)
Point-of-Sale and Prepaid Services   (544,835)   67,704 
Other Corporate Overhead   -    (589)
Total  $(2,654,666)  $(3,443,075)

 

   For the Three Months Ended June 30, 
   2025   2024 
         
Gross Margin:          
Mobile Virtual Network Operator  %(92.8)  %(28.1)
Point-of-Sale and Prepaid Services   (5.9)   2.6 
Other Corporate Overhead   -    (24.9)
Total  %(23.0)  %(22.8)

 

The Company expects to continue the improvement of gross margin in the Point-of-Sale and Prepaid Services segment during 2025. Most of the cost to get Clearline ready for launch has occurred and we expect the gross margin to be positive by the end of 2025 for this revenue channel. As we continue to expand both subsidized (Lifeline) and non-subsidized products (LinkUp Mobile) of the MNVO segment in 2025, we also anticipate gross margins in the MVNO segment will increase with an aim to return to positive results.

 

General and administrative during the three months ended June 30, 2025 and 2024 consisted of the following:

 

   2025   2024 
Depreciation and amortization  $229,817   $289,468 
Selling, general and administration   3,926,026    7,143,510 
Total  $4,155,843   $7,432,978 

 

65

 

 

Selling, general and administrative expenses during the three months ended June 30, 2025 and 2024 consisted of the following:

 

   2025   2024 
Contractors and consultants  $500,448   $954,777 
Professional services   309,391    599,223 
Compensation   1,814,269    4,421,114 
Computer and internet   247,771    226,644 
Advertising and marketing   14,143    11,045 
Insurance   283,377    288,500 
Other   756,627    642,207 
Total  $3,926,026   $7,143,510 

 

Selling, general and administrative costs (S, G & A) decreased by $3,217,484 (45.0%). The changes are discussed below:

 

Contractors and consultants expense decreased by $454,329 or 47.6% from $954,777 for the three months ended June 30, 2024 to $500,448 for the three months ended June 30, 2025. The Company decreased the spend in the period ending June 30, 2025 by over $400,000 compared to the period ending June 30, 2024, due to the reduction in advisory services specifically in the area of investment relations.
   
Professional services decreased $289,832 or 48.4% from the three months ended June 30, 2024 to the three months ended June 30, 2025 primarily due to a decrease in legal fees of $324,208. Primarily due to the legal settlement of the Consumer Attorney Marketing Group, LLC case paid in the second quarter of 2024.
   
Compensation decreased from $4,421,114 or 59.0% reduction for the three months June 30, 2024 to $1,814,269 for the three months ended June 30, 2025, primarily as a result of the change in one-time non-cash component for stock compensation for the CEO and CFO of $2,826,458 for the period ending June 30, 2025 compared to the period ending June 30, 2024.
   
Computer and internet costs increased $21,127 or 9.3% from the three months ended June 30, 2024 to the three months ended June 30, 2025. The increase was primarily the result of increased costs for Amazon Web Services (AWS) for support services related to the maintenance and cloud services.
   
Advertising and marketing costs increased to $14,143 or a 28.1% increase for the three months ended June 30, 2025 from $11,045 for the three months ended June 30, 2024, primarily additional marketing of the Clearline platform.
   
Insurance expense decreased to $283,377 or a 1.8% reduction for the three months ended June 30, 2025 from $288,500 for the three months ended June 30, 2024.
   
Other costs increased $114,419 or 17.8 % from the three months ended June 30, 2024 to the three months ended June 30, 2025. Most of the increase was related to the opening of the business process outsourcing center in San Salvador.

 

66

 

 

Other (expense) income during the three months ended June 30, 2025 and 2024 consisted of the following:

 

   2025   2024 
Interest, net  $(212,419)  $(116,722)
Interest income   7,008    - 
Amortization of debt discount   (66,887)   

-

 
Other income   

-

    636,868 
Gain (loss) on equity investment in Centercom   

-

    17,711 
Total other (expense) income  $(272,298)  $537,857 

 

Interest expense increased to $212,419 in the three months ended June 30, 2025 from $116,722 in the three months ended June 30, 2024.

 

In connection with the issuance of the $6,999,999 convertible promissory note, the Company issued warrants to purchase 700,000 shares of common stock. The Company allocated a portion of the proceeds to the warrants based on their relative fair value, determined using the Black-Scholes option pricing model. The fair value of the warrants was estimated to be $207,640, which was recorded as a component of the total debt discount and is being amortized to interest expense over the term of the note.

 

The equity investment in Centercom changed by $0 in the three months ended June 30, 2025 compared to an increase of $17,711 in the three months ended June 30, 2024. As of December 31, 2024, The Company determined that it would no longer utilize the Business Process Outsourcing (BPO) services of CenterCom. As of December 31, 2024, the Company assessed its investment in CenterCom and determined there was an impairment. Factors leading to this decision included a change in ownership and large reduction in human capital. As a result, CenterCom was materially impacted and could no longer continue its operations.

 

Provision for income tax benefit (expense) during the three months ended June 30, 2025 and 2024 consisted of the following:

 

   2025   2024 
Current  $-   $5,000 
Deferred   -    2,542,000 
Total provision (benefit)  $-   $2,547,000 

 

67

 

 

COMPARISON OF SIX MONTHS ENDED June 30, 2025 AND 2024

 

Reclassifications

 

Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the consolidated results of operations, stockholders’ deficit, or cash flows.

 

We measure our performance on a consolidated basis as well as the performance of each segment.

 

We report our financial performance based on the following segments: Mobile Virtual Network Operators (MVNO), and Point-of-Sale and Prepaid Services (Top-up). The MVNO segment is further broken down into subsidized (Lifeline) and non-subsidized components (LinkUp Mobile). The subsidized component or Lifeline is the result of the mobile broadband (phone and internet) services provided by Torch Wireless to eligible consumers. The Point-of-Sale and Prepaid Services segment is comprised of Surge Fintech and ECS as previously shown.

 

The segment amounts included in MD&A are presented on a basis consistent with our internal management reporting. Additional information on our reportable segments is contained in Note 10 – Segment Information and Geographic Data of the Notes to Financial Statements.

 

Revenues during the six months ended years ended June 30, 2025 and 2024 consisted of the following:

 

   2025   2024 
Revenue  $22,095,596   $46,514,834 
Cost of revenue (exclusive of depreciation and amortization)   (27,692,607)   (41,775,243)
General and administrative   (8,793,401)   (13,863,783)
Loss from operations  $(14,390,412)  $(9,124,192)

 

Revenue decreased overall by $24,419,238 (52.5%) from the six months ended June 30, 2024 to the six months ended June 30, 2025. The breakout was as follows:

 

   For the Six Months Ended June 30, 
   2025   2024 
         
Revenues:          
Mobile Virtual Network Operator  $4,559,530   $41,396,096 
Point-of-Sale and Prepaid Services   17,536,066    5,107,409 
Other Corporate Overhead   -    11,329 
Total  $22,095,596   $46,514,834 

 

Mobile Virtual Network Operators consisting of SurgePhone Wireless and Torch Wireless revenues (as detailed in Notes 2 and 10 of the financial statements) decreased by $36,836,567 (89.0%). Due to a lack of additional funding from Congress, April 2024 was the last month ACP households received the full ACP discount, as they had received in prior months, and effective June 1, 2024, households no longer receive an ACP discount.

 

The Company signed a Master Services Agreement (MSA) with TerraCom, Inc. (“TerraCom”), a wireless service provider and licensed Lifeline provider, effective October 3, 2024, in order to execute the strategy of offering Lifeline to our existing ACP subscriber base. This agreement allowed us to offer a government-subsidized program to our previous 250,000 ACP wireless subscribers. We transitioned over 80,000 subscribers to the Lifeline program during 2024. Equally important, this allows us to reignite our sales channels to acquire new Lifeline subscribers who lost their ACP service when their carrier chose to shut them off.

 

Point-of-Sale and Prepaid Services (Prepaid) revenues increased by $12,428,657 as a result of increasing our sales force and hiring of a new Director of Sales and renewed focus on this segment of the business. The Company expects this segment to continue to grow for the remainder of 2025.

 

Effective December 31, 2024, the Company’s management elected to abandon its lead generation segment operations as part of a strategic reassessment of its business lines. This decision followed a review by the Chief Operating Decision Maker (“CODM”, which is our Chief Executive Officer), who had been regularly evaluating the segment’s financial performance and determined that its continued operation was no longer aligned with the Company’s long-term strategic objectives. The revenue was $0 and $0 respectively in the year ended December 31, 2024 and in the six months ended June 30, 2025 Comparison numbers for the lead generation segment are shown in the respective Other Corporate Overhead lines.

 

68

 

 

Cost of Revenue, Gross Profit and Gross Margin

 

For the six months ended June 30, 2025, cost of revenue for services primarily consists of data plan expenses ($4,790,868), prepaid retail expenses ($18,118,971), devices ($873,276), marketing ($493,368), advertising ($847,778) and other expenses such as royalties and call-center expenses ($2,568,346). For the six months ended June 30, 2024, cost of revenue for services primarily consists of data plan expenses ($17,990,820), devices ($4,826,022), marketing ($11,562,415), advertising ($4,315,402) and other expenses such as royalties and call-center expenses ($3,080,584).

 

We expect that our cost of revenue will increase or decrease to the extent that our revenue increases and decreases.

 

   For the Six Months Ended June 30, 
   2025   2024 
Cost of Revenue (exclusive of depreciation and amortization):          
Mobile Virtual Network Operator  $9,573,155   $36,773,896 
Point-of-Sale and Prepaid Services   18,118,971    4,990,922 
Other Corporate Overhead   481    10,425 
Total  $27,692,607   $41,775,243 

 

Gross profit margin is calculated as revenue less cost of revenue. Gross profit margin is gross profit expressed as a percentage of revenue. Our gross profit in future periods will depend on a variety of factors, including market conditions that may impact our pricing, sales mix among devices, sales mix changes among consumables, excess and obsolete inventories, and the cost of our products from manufacturers. Our gross profit in future periods will vary based upon our revenue stream mix and may increase based upon our distribution channels

 

   For the Six Months Ended June 30, 
   2025   2024 
         
Gross Profit (Loss) (exclusive of depreciation and amortization):          
Mobile Virtual Network Operator  $(5,013,626)  $4,622,200 
Point-of-Sale and Prepaid Services   (583,385)   116,487 
Other Corporate Overhead   -    904 
Total  $(5,597,011)  $4,739,591 

 

   For the Six Months Ended June 30, 
   2025   2024 
         
Gross Margin:          
Mobile Virtual Network Operator  %(110.0)  %11.2 
Point-of-Sale and Prepaid Services   (3.3)   2.3 
Other Corporate Overhead   -    39.2 
Total  %(25.3)  %10.2 

 

The Company expects to continue the improvement of gross margin in the Point-of-Sale and Prepaid Services segment during 2025. Most of the cost to get Clearline ready for launch has occurred and we expect the gross margin to be positive by the end of 2025 for this revenue channel. As we continue to expand both subsidized (Lifeline) and non-subsidized products (LinkUp Mobile) of the MNVO segment in 2025, we also anticipate gross margins in the MVNO segment will increase with an aim to return to positive results.

 

General and administrative during the six months ended June 30, 2025 and 2024 consisted of the following:

 

   2025   2024 
Depreciation and amortization  $479,391   $578,935 
Selling, general and administration   8,314,010    13,284,848 
Total  $8,793,401   $13,863,783 

 

69

 

 

Selling, general and administrative expenses during the six months ended June 30, 2025 and 2024 consisted of the following:

 

   2025   2024 
Contractors and consultants  $1,345,542   $2,179,656 
Professional services   475,204    1,302,670 
Compensation   3,544,709    7,609,142 
Computer and internet   506,857    436,191 
Advertising and marketing   37,623    27,851 
Insurance   566,580    572,375 
Other   1,837,495    1,156,963 
Total  $8,314,010   $13,284,848 

 

Selling, general and administrative costs (S, G & A) decreased by $4,970,838 (37.4%). The changes are discussed below:

 

Contractors and consultants expense decreased by $834,114 or 38.3% from $2,179,656 for the six months ended June 30, 2024 to $1,345,542 for the six months ended June 30, 2025. The Company decreased the spend in the period ending June 30, 2025 compared to the period ending June 30, 2024, with a reduction in spend of $911,742 in common stock issued for services and advisory services the area of investment relations.
   
Professional services decreased $827,466 or 63.5% from the six months ended June 30, 2024 to the six months ended June 30, 2025 primarily due to a decrease in legal fees of $877,734.
   
Compensation decreased from $7,609,142 or a 53.4% reduction for the six months June 30, 2024 to $3,544,709 for the six months ended June 30, 2025, primarily as a result of change in one-time non-cash component for stock compensation for the CEO and CFO of $4,168,756 for the period ending June 30, 2025 compared to the period ending June 30, 2024
   
Computer and internet costs increased $70,666 or 16.2% from the six months ended June 30, 2024 to the six months ended June 30, 2025. The increase was primarily the result of increased programming and support services related Amazon Web Services (AWS).
   
Advertising and marketing costs increased to $37,623 or a 35.1% increase for the six months ended June 30, 2025 from $27,851 for the six months ended June 30, 2024, primarily additional marketing of the Clearline platform.
   
Insurance expense increased to $566,580 or a 1.0% reduction for the six months ended June 30, 2025 from $572,375 for the six months ended June 30, 2024.
   
Other costs increased $680,532 or 58.8 % from the six months ended June 30, 2024 to the six months ended June 30, 2025. Most of the increase was related to sales tax in various states.

 

70

 

 

Other (expense) income during the six months ended June 30, 2025 and 2024 consisted of the following:

 

   2025   2024 
Interest expense  $(331,853)  $(249,305)
Interest income   64,267    - 
Amortization of debt discount   (66,887)     
Other income   6,785    636,868 
Gain (loss) on equity investment in Centercom        33,864
Total other (expense) income  $(327,688)  $421,427 

 

Interest expense increased to $331,853 in the six months ended June 30, 2025 from $249,305 in the six months ended June 30, 2024.

 

In connection with the issuance of the $6,999,999 convertible promissory note, the Company issued warrants to purchase 700,000 shares of common stock. The Company allocated a portion of the proceeds to the warrants based on their relative fair value, determined using the Black-Scholes option pricing model. The fair value of the warrants was estimated to be $207,640, which was recorded as a component of the total debt discount and is being amortized to interest expense over the term of the note.

 

The equity investment in Centercom changed by $0 in the six months ended June 30, 2025 compared to an increase of $33,864 in the six months ended June 30, 2024. As of December 31, 2024, The Company determined that it would no longer utilize the Business Process Outsourcing (BPO) services of CenterCom. As of December 31, 2024, the Company assessed its investment in CenterCom and determined there was an impairment. Factors leading to this decision included a change in ownership and large reduction in human capital. As a result, CenterCom was materially impacted and could no longer continue its operations.

 

Provision for income tax benefit (expense) during the six months ended June 30, 2025 and 2024 consisted of the following:

 

   2025   2024 
Current  $-   $135,000 
Deferred   -    2,835,000 
Total provision (benefit)  $-   $2,970,000 

 

Equity Transactions for the Six Months Ended June 30, 2025

 

Treasury Stock

 

The Company repurchased 333,333 shares of its common stock from a convertible note payable holder for $999,999 ($3/share). In connection with the transaction, the principal balance of the related convertible note was increased by $999,999.

 

Segment Information

 

Operating segments are defined as components of an enterprise about which separate financial information is available and evaluated regularly by the chief operating decision maker, or decision–making group, in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision maker is its Chief Executive Officer.

 

The Company evaluated the performance of its operating segments based on revenues and operating income (loss). Segment information for the three months ended June 30, 2025 and 2024, are as follows:

 

Segment information for the Company’s operations for the three and six months ended June 30, 2025 and 2024, are as follows:

 

   For the Three Months Ended
June 30,
   For the Six Months Ended
June 30,
 
   2025   2024   2025   2024 
                 
Revenues                    
Mobile Virtual Network Operators  $2,273,706   $12,503,507   $4,559,530   $41,396,096 
Point-of-Sale and Prepaid Services   9,244,460    2,576,820    17,536,066    5,107,409 
Other Corporate Overhead   -    5,372    -    11,329 
Total  $11,518,166   $15,085,699   $22,095,596   $46,514,834 
                     
Cost of revenues                    
Mobile Virtual Network Operators  $4,383,537   $16,013,697   $9,573,155   $36,773,896 
Point-of-Sale and Prepaid Services   9,789,295    2,509,116    18,119,452    4,990,922 
Other Corporate Overhead   -    5,961    -    10,425 
Total  $14,172,832   $18,528,774   $27,692,607   $41,775,243 
                     
Operating expenses                    
Mobile Virtual Network Operators  $285,526   $34,548   $881,752   $69,379 
Point-of-Sale and Prepaid Services   658,727    779,225    1,565,723    1,498,590 
Other Corporate Overhead   3,211,590    6,619,205    6,345,926    12,295,814 
Total  $4,155,843   $7,432,978   $8,793,401   $13,863,783 
                     
Income (loss) from operations                    
Mobile Virtual Network Operators  $(2,395,357)  $(3,544,738)  $(5,895,377)  $4,552,821 
Point-of-Sale and Prepaid Services   (1,203,562)   (711,521)   (2,148,109)   (1,382,103)
Other Corporate Overhead   (3,211,590)   (6,619,794)   (6,346,926)   (12,294,910)
Total  $(6,810,509)  $(10,876,053)  $(14,390,412)  $(9,124,192)

 

71

 

 

Segment information for the Company’s assets and liabilities at June 30, 2025 and December 31, 2024, are as follows:

 

   June 30, 2025   December 31, 2024 
         
Total Assets          
Mobile Virtual Network Operators  $5,690,101   $8,472,349 
Point-of-Sale and Prepaid Services   5,040,231    4,884,817 
Other Corporate Overhead   4,485,077    10,618,839 
Total  $15,215,409   $23,976,005 
           
Total Liabilities          
Mobile Virtual Network Operators  $1,835,032   $1,505,400 
Point-of-Sale and Prepaid Services   696,235    103,612 
Other Corporate Overhead   12,622,750    7,105,380 
Total  $15,154,017   $8,714,392 

 

All intercompany accounts are separately presented above as both a component of the assets and liabilities. These amounts net to $0 in the Company’s consolidated balance sheets.

 

Mobile Virtual Network Operator

 

The MVNO revenue for the three months ended June 30, 2025 decreased by $10,229,801 as compared to the three months ended June 30, 2024. Cost of revenues for the three months ended June 30, 2025, decreased by $11,630,159 from the same period ended June 30, 2024, as a result of the lack of additional funding from Congress, April 2024 was the last month ACP households received the full ACP discount, as they had received in prior months, and effective June 1, 2024, households no longer receive an ACP discount.

 

The MVNO revenue for the six months ended June 30, 2025 decreased by $36,836,567 as compared to the six months ended June 30, 2024. Cost of revenues for the six months ended June 30, 2025, decreased by $27,200,741 from the same period ended June 30, 2024, as a result of the lack of additional funding from Congress, April 2024 was the last month ACP households received the full ACP discount, as they had received in prior months, and effective June 1, 2024, households no longer receive an ACP discount.

 

Point-of-Sale and Prepaid Services

 

The revenue for the three months ended June 30, 2025 was $9,244,460 compared to $2,576,820 for the same period in 2024. The increase of 58.8% was the result of hiring new salespersons and a renewed focus on the market segment.

 

The revenue for the six months ended June 30, 2025 was $17,536,066 compared to $5,107,409 for the same period in 2024. The increase of 243.3% was the result of hiring new salespersons and a renewed focus on the market segment.

 

Overall

 

The overall decrease in revenue of $24,419,238 from 2024 to 2025 for the six months ended June 30, can be attributed to the elimination of the ACP during the first half of 2024.

 

LIQUIDITY AND CAPITAL RESOURCES

 

At June 30, 2025 and December 31, 2024, our current assets were $9,694,382 and $17,870,323, respectively, and our current liabilities were $8,702,069 and $6,059,476, respectively, which resulted in a working capital surplus of $992,313 and of $11,810,847, respectively.

 

Total assets at June 30, 2025 and December 31, 2024 amounted to $15,215,409 and $23,976,005, respectively. Total assets decreased by $8,760,596 from December 31, 2024 to June 30, 2025. At June 30, 2025, assets consisted of current assets of $9,694,382, net property and equipment of $457,195, net intangible assets of $1,145,756, goodwill of $3,300,000, note receivable of $176,851 and operating lease right of use asset of $441,225, compared to at December 31, 2024, current assets of $17,870,323, net property and equipment of $591,088, net intangible assets of $1,472,962, goodwill of $3,300,000, note receivable of $176,851, and operating lease right of use asset of $564,781.

 

At June 30, 2025, our total liabilities were $15,154,017 compared to total liabilities of $8,714,392 at December 31, 2024. This $6,439,625 increase was related to on May 12, 2025, the Company entered into a Senior Secured Note Purchase Agreement with Funicular Funds, LP (the “Investor”), pursuant to which the Company issued a Senior Secured Convertible Note in the original principal amount of $6,999,999 (the “Note”). The transaction resulted in net cash proceeds of $6,000,000 to the Company and included the repurchase of 333,333 shares of the Company’s common stock from the Investor at $3/share. These repurchased shares will be cancelled and retired, and the corresponding shares will not be returned to the pool of authorized but unissued shares, and remain as treasury stock. We have also entered into an At The Market Offering Agreement (the “ATM Agreement”) with Titan Partners Group LLC, a division of American Capital Partners, LLC (“Titan”), pursuant to which the Company may offer and sell shares of its common stock (subject to certain limitations set forth in the ATM Agreement), from time to time, to or through Titan, acting as sales agent and/or principal. In accordance with the terms of the ATM Agreement, under the Prospectus Supplement, the Company may offer and sell shares of its common stock having an aggregate offering price of up to $15,000,000, from time to time, to or through Titan, which is within the Company’s current “baby shelf” limitations under General Instruction I.B.6. of Form S-3. We plan to utilize the ATM Agreement when appropriate to fund our working capital needs on an ongoing basis.

 

At June 30, 2025, our total stockholders’ equity was $61,392 as compared to $15,261,613 at December 31, 2024.

 

72

 

 

The following table sets forth the major sources and uses of cash for the six months ended June 30, 2025 and 2024.

 

   2025   2024 
         
Net cash provided by operating activities  $(13,082,419)  $(90,112)
Net cash used in investing activities   (18,590)   - 
Net cash provided by (used in) financing activities   4,715,069    23,902,632 
Net change in cash and cash equivalents  $(8,385,940)  $23,812,520 

 

Net cash used in operating activities for the six months ended June 30, 2025, was primarily due to the net loss for the period of $14,718,100.

 

Net cash used in investing activities for the six months ending June 30, 2025 was primarily due to payment for leases.

 

Net cash used for financing activities for the six months ended June 30, 2025 is primarily due to proceeds from a convertible note.

 

As a result of net negative cash provided by operating activities and investing activities in 2025, our overall cash decreased in 2025 by $8,385,940, compared to an increase of cash in 2024 primarily driven by net cash provided for by a capital raise and exercise of warrants $23,812,520.

 

At June 30, 2025, the Company had the following material commitments and contingencies.

 

Notes payable – related party - See Note 6 to the Consolidated Financial Statements.

 

Notes payable and long-term debt - See Note 6 to the Consolidated Financial Statements.

 

Related party transactions - See Note 2 to the Consolidated Financial Statements for additional discussion.

 

Cash requirements and capital expenditures – As we transition from the end of the ACP program in 2024 and the reduction in total revenues and margins, we may not have sufficient resources to continue to fund operations for the next twelve months without additional funding.

 

In order to fund the expected growth and on-going expenses, we plan to selectively use the ATM agreement previously disclosed. In addition, we have suspended the monthly payment on the related party note (see Note 6) until further notice. We are currently exploring various strategic opportunities; however, we have no commitments at this time and no known timing as to when any transaction may occur. We will only pursue options that we believe are in the best interest of, and on the best terms for, the Company. We believe these cash sources will be sufficient to get the Company to the fourth quarter of 2025, at which time we expect to return to profitability and generate enough cash flow to fund on-going operations.

 

The Company kicked off several initiatives in April of 2025. We have begun the launch of LinkUp Mobile SIM (subscriber identity module) cards into the national retail market. LinkUp Mobile has also launched its phone in a box program. Thousands of phones have already been purchased by convenience stores, which we believe is a positive sign for our future capabilities. Torch Wireless, supported by the Lifeline program, is now actively expanding its subscriber base in the state of California. This development is noteworthy for the growth of the Torch offering, as California provides an additional revenue incentive for its subscribers and has a large potential subscriber base. The wholesale MVNE (Mobile Virtual Network Enabler) leveraging technology and industry expertise has allowed us to expand services as a Mobile Network Enabler. Leveraging our direct carrier relationship, we offer billing, provisioning, SIM cards, and services to wireless companies lacking direct carrier access. Two such companies have already embraced this offering, and we anticipate more to join in the near future. We believe the MVNE solution will continue to uniquely position us for additional rapid growth into the subscriber activation channel by enabling other wireless companies who lack a direct carrier relationship. Clear-line has launched a comprehensive code management campaign, providing services to over 1,600 convenience stores. In addition to this new business venture, Shortcode, the ability to dynamic content and features into posts, pages and widgets, has been provisioned with all carriers in preparation for a national campaign scheduled to launch in July.

 

Known trends and uncertainties – The Company continues to explore potential strategic opportunities to acquire other businesses with similar business operations, or businesses we believe could be potentially symbiotic. While we are currently exploring various strategic opportunities, we have no commitments at this time and no known timing as to when any opportunities may arise. We will only pursue opportunities that we believe are in the best interest of, and on the best terms for, the Company.

 

Critical Accounting Policies and Estimates

 

Management’s discussion and analysis of our financial condition and results of operations is based on our consolidated financial statements, which were prepared in accordance with U.S. generally accepted accounting principles, or GAAP. The preparation of these consolidated financial statements requires us to make estimates and assumptions for the reported amounts of assets, liabilities, revenue and expenses. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions, and any such differences may be material.

 

While our significant accounting policies are more fully described in Note 2Summary of Significant Accounting Policies of the Notes to Consolidated Financial Statements included in Item 8, Financial Statements and Supplementary Data of this Annual Report on Form 10-K, we believe the following discussion addresses our most critical accounting policies, which are those that are most important to our financial condition and results of operations and which require our most difficult, subjective and complex judgments.

 

Use of Estimates

 

Preparing financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates, and those estimates may be material.

 

Significant estimates during the six months ended June 30, 2025 and 2024, respectively, include, allowance for doubtful accounts and other receivables, inventory reserves and classifications, valuation of loss contingencies, valuation of derivative liabilities, valuation of stock-based compensation, estimated useful lives related to intangible assets, capitalized internal-use software development costs, and property and equipment, implicit interest rate in right-of-use operating leases, uncertain tax positions, and the valuation allowance on deferred tax assets.

 

73

 

 

Fair Value of Financial Instruments

 

The Company accounts for financial instruments under Financial Accounting Standards Board (“FASB”) ASC 820, Fair Value Measurements. ASC 820 provides a framework for measuring fair value and requires disclosures regarding fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, based on the Company’s principal or, in absence of a principal, most advantageous market for the specific asset or liability.

 

The Company uses a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable inputs, when determining fair value.

 

The three tiers are defined as follows:

 

  Level 1 - Observable inputs that reflect quoted market prices (unadjusted) for identical assets or liabilities in active markets;
  Level 2 - Observable inputs other than quoted prices in active markets that are observable either directly or indirectly in the marketplace for identical or similar assets and liabilities; and
  Level 3 - Unobservable inputs that are supported by little or no market data, which require the Company to develop its own assumptions.

 

The determination of fair value and the assessment of a measurement’s placement within the hierarchy requires judgment. Level 3 valuations often involve a higher degree of judgment and complexity. Level 3 valuations may require the use of various cost, market, or income valuation methodologies applied to unobservable management estimates and assumptions. Management’s assumptions could vary depending on the asset or liability valued and the valuation method used. Such assumptions could include estimates of prices, earnings, costs, actions of market participants, market factors, or the weighting of various valuation methods. The Company may also engage external advisors to assist us in determining fair value, as appropriate.

 

Impairment of Long-lived Assets

 

Management evaluates the recoverability of the Company’s identifiable intangible assets and other long-lived assets when events or circumstances indicate a potential impairment exists, in accordance with the provisions of ASC 360-10-35-15 “Impairment or Disposal of Long-Lived Assets.” Events and circumstances considered by the Company in determining whether the carrying value of identifiable intangible assets and other long-lived assets may not be recoverable include but are not limited to significant changes in performance relative to expected operating results; significant changes in the use of the assets; significant negative industry or economic trends; and changes in the Company’s business strategy. In determining if impairment exists, the Company estimates the undiscounted cash flows to be generated from the use and ultimate disposition of these assets.

 

If impairment is indicated based on a comparison of the assets’ carrying values and the undiscounted cash flows, the impairment to be recognized is measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets.

 

Inventory Valuation

 

Inventory is stated at the lower of cost or net realizable value (average cost). For items manufactured by third parties, cost is determined using the weighted average cost method (WAC). We write down inventory when it has been determined that conditions exist that may not allow the inventory to be sold for at the intended price or the inventory is determined to be obsolete based on assumption about future demand and market conditions. The charge related to inventory write-downs is recorded as cost of goods sold. We evaluate inventory at least annually and at other times during the year. We have incurred and may in the future incur charges to write down inventory.

 

74

 

 

Revenue from Contracts with Customers

 

We account for revenue earned from contracts with customers under ASC 606, Revenue from Contracts with Customers (“ASC 606”), and ASC 842, Leases (“ASC 842”). The core principle of ASC 606 is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. The following five steps are applied to achieve that core principle:

 

● Step 1: Identify the contract with the customer.

● Step 2: Identify the performance obligations in the contract.

● Step 3: Determine the transaction price.

● Step 4: Allocate the transaction price to the performance obligations in the contract.

● Step 5: Recognize revenue when, or as, the company satisfies a performance obligation.

 

Stock-Based Compensation

 

The Company accounts for our stock-based compensation under ASC 718 “Compensation – Stock Compensation” using the fair value-based method. Under this method, compensation cost is measured at the grant date based on the value of the award and is recognized over the service period, which is usually the vesting period. This guidance establishes standards for the accounting for transactions in which an entity exchanges its equity instruments for goods or services. It also addresses transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity’s equity instruments or that may be settled by the issuance of those equity instruments.

 

The Company uses the fair value method for equity instruments granted to non-employees and use the Black-Scholes model for measuring the fair value of options.

 

The fair value of stock-based compensation is determined as of the date of the grant or the date at which the performance of the services is completed (measurement date) and is recognized over the vesting periods.

 

Stock Warrants

 

In connection with certain financing (debt or equity), consulting and collaboration arrangements, the Company may issue warrants to purchase shares of its common stock. The outstanding warrants are standalone instruments that are not puttable or mandatorily redeemable by the holder and are classified as equity awards. The Company measures the fair value of warrants issued for compensation using the Black-Scholes option pricing model as of the measurement date. However, for warrants issued that meet the definition of a derivative liability, fair value is determined based upon the use of a binomial pricing model.

 

75

 

 

Warrants issued in conjunction with the issuance of common stock are initially recorded at fair value as a reduction in additional paid-in capital of the common stock issued. All other warrants (for services) are recorded at fair value and expensed over the requisite service period or at the date of issuance if there is not a service period.

 

Recent Accounting Pronouncements

 

In the normal course of business, we evaluate all new accounting pronouncements issued by the Financial Accounting Standards Board, SEC, or other authoritative accounting bodies to determine the potential impact they may have on our Consolidated Financial Statements. Refer to Note 2 - Summary of Significant Accounting Policies of the Notes to Consolidated Financial Statements.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of disclosure controls and procedures

 

Under the PCAOB standards, a control deficiency exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A significant deficiency is a deficiency, or a combination of deficiencies, in internal control over financial reporting that is less severe than a material weakness, yet important enough to merit the attention by those responsible for oversight of the company’s financial reporting. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis.

 

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of our disclosure controls and procedures, as such term is defined under Rule 13a-15(e) and Rule 15d-15(e) promulgated under the Securities Exchange Act of 1934, as amended (Exchange Act). Our management has determined that, as of June 30, 2025, the Company’s disclosure controls are effective, but the Company lacks segregation of duties similar to other companies our size.

 

Changes in Internal Control over Financial Reporting

 

During the period ended June 30, 2025, there were no changes in our internal controls over financial reporting, which were identified in connection with our management’s evaluation required by paragraph (d) of rules 13a-15 and 15d-15 under the Exchange Act, that materially affected, or is reasonably likely to have a material effect, on our internal control over financial reporting.

 

PART II - OTHER INFORMATION

 

ITEM 1: LEGAL PROCEEDINGS

 

From time to time, we may be engaged in various lawsuits and legal proceedings in the ordinary course of our business. Except as described below, we are currently not aware of any legal proceedings the ultimate outcome of which, in our judgment based on information currently available, would have a material adverse effect on our business, financial condition or results of operations.

 

The following is a summary of threatened, pending, asserted or unasserted claims against us or any of our wholly owned subsidiaries for which there have been material developments:.

 

  (1) Juno Financial v. AATAC and Surge Holdings Inc. and Surge Holdings Inc. v. AATAC; Circuit Court of Hillsborough County, Florida, Case # 20-CA-2712 DIV A: Breach of Contract, Account Stated and Open Account claims against Surge by a factoring company. Surge has filed a cross-complaint against defendant AATAC for Breach of Contract, Account Stated, Open Account and Common Law Indemnity. The Court dismissed the case with the agreement of the parties at a case management conference on September 12, 2024.

 

76

 

 

  (2)

Blue Skies Connections, LLC, and True Wireless, Inc. v. SurgePays, Inc., et. al.: In the District Court of Oklahoma County, OK, CJ-2021-5327, filed on December 13, 2021. Plaintiffs’ petition alleges breach of a Stock Purchase Agreement by SurgePays, SurgePhone Wireless, LLC, and Kevin Brian Cox (“Defendants”), and makes other allegations related to SurgePays’ consulting work with Jonathan Coffman, formerly a True Wireless employee. The petition requests injunctive relief, general damages, punitive damages, attorney fees and costs for alleged breach of contract, tortious interference with a business relationship, and fraud. Blue Skies alleged the Defendants are in violation of their non-competition and non-solicitation agreements related to the sale of True Wireless from SurgePays to Blue Skies. Defendants filed various dispositive motions with the Court demonstrating Oklahoma state law does not recognize non-compete agreements and non-solicitation agreements in the manner alleged by Plaintiffs, and the Court granted these motions, finding the non-solicitation and non-competition clauses in the Stock Purchase Agreement void as a matter of Oklahoma law. Defendants then filed additional dispositive motions on Plaintiffs’ claims in tort and equity, which the Court granted in part based on its prior rulings. Plaintiffs took the position the Court granting Defendants’ dispositive motions on these material issues only leaves partial contract claims that are inextricably intertwined with the remaining claims and defenses. Plaintiffs sought a certified interlocutory appeal of the Court’s orders. On March 10, 2025, the Oklahoma Supreme Court entered an order denying Plaintiffs’ Petition for Certiorari to review the certified interlocutory appeal. The case will now proceed in the district court on the parties’ remaining claims. Both parties have filed motions for summary judgment on the remaining claims, which will be decided in Fall of 2025. Presently, there is no trial date. An attempt at mediation in July 2022 did not achieve a settlement. Any further settlement discussions will occur in the context of Defendants having prevailed on the majority of Plaintiffs’ claims.

     
  (3)

SurgePays, Inc. et al. v. Fina et al., Case No. CJ-2022-2782, District Court of Oklahoma County, Oklahoma. Plaintiffs SurgePays, Inc. and Kevin Brian Cox initiated this case against its former officer Mike Fina, his companies Blue Skies Connections, LLC, True Wireless, Inc., Government Consulting Solutions, Inc., Mussell Communications LLC, and others. This case also arises from the June 2021 transaction by which SurgePays sold True Wireless to Blue Skies. During the litigation of CJ-2021-5327 described above, SurgePays learned information that showed Mike Fina breached his duties owed to True Wireless during his employment and consulting work for True Wireless prior to SurgePays’ sale of True Wireless to Blue Skies. SurgePays alleges that Mike Fina conspired with the other defendants to damage True Wireless thereby harming the value of the company and causing its eventual sale at a greatly reduced price. SurgePays asserts claims for (i) breach of contract; (ii) breach of fiduciary duty; (iii) fraud; (iv) tortious interference; and (v) unjust enrichment. At this stage, no defendant has asserted a counterclaim against SurgePays. SurgePays filed a Second Amended Petition on January 27, 2023. Defendants Fina, Blue Skies, True Wireless, and Government Consulting Solutions filed a Motion to Dismiss on March 10, 2023. On June 29, 2023, the Court granted the Motion to Dismiss, ruling the claims asserted are “derivative” and could only be asserted by the True Wireless entity now owed by Blue Skies. The Court rejected SurgePays’ request to certify this ruling for immediate appeal. Defendant Misty Garrett filed a Motion for Summary Judgment seeking the same relief as the Motion to Dismiss, which was granted by the Court.

 

All claims against all parties have been adjudicated by the Court. SurgePays filed a Motion for New Trial, which was denied by the Court on February 20, 2025.  SurgePays’ has filed an appeal of the Court’s dismissal of Fina, Blue Skies, True Wireless, Government Consulting Solutions, and summary judgment for Misty Garrett. At this stage, no attempts at settlement have been made.

 

77

 

 

ITEM 1A: RISK FACTORS

 

Not applicable.

 

ITEM 2: UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

On May 12, 2025, the Company entered into a Senior Secured Note Purchase Agreement with Funicular Funds, LP, pursuant to which the Company issued a Senior Secured Convertible Note in the original principal amount of $6,999,999 (the “Note”). The Note includes an embedded conversion option, which permits the Investor to convert the outstanding principal and accrued interest into shares of the Company’s common stock (the “Conversion Shares”) at an initial conversion price of $4.00 per share. The conversion price is subject to down-round adjustment if the Company issues common stock (or equivalents) at a price below the then-current conversion price. The transaction resulted in net cash proceeds of $5,925,000 to the Company.

 

ITEM 3: DEFAULTS UPON SENIOR SECURITIES.

 

None

 

ITEM 4: MINE SAFETY DISCLOSURES.

 

Not applicable

 

ITEM 5: OTHER INFORMATION.

 

For the six months ended June 30, 2025, none of our directors or executive officers adopted, modified or terminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement” (as defined in Item 408 of Regulation S-K).

 

Issuer Purchases of Equity Securities

 

On May 12, the Company repurchased 333,333 shares of its common stock from a convertible note payable holder for $999,999 ($3/share). In connection with the transaction, the principal balance of the related convertible note was increased by $999,999.

 

On August 13, 2024, the Company entered into a share repurchase program with ThinkEquity LLC for up to $5,000,000 shares of its common stock. During the three months ended September 30, 2024, the Company reacquired, on the open market, 81,850 shares of stock for $146,836, at an average price of $1.79/share. All shares purchased are intended to qualify for the safe harbor in rule 10b-18. On October 1, 2024, the Company decided to terminate the share repurchase program and will no longer be making any reacquisitions.

 

ITEM 6: EXHIBITS

 

Exhibit    
Number   Exhibit Description
31.1*   Certification pursuant to 18 U.S.C. Section 1350 Section 302 of the Sarbanes-Oxley Act of 2002 - Chief Executive Officer
31.2*   Certification pursuant to 18 U.S.C. Section 1350 Section 302 of the Sarbanes-Oxley Act of 2002 - Chief Financial Officer
32.1**   Certification pursuant to 18 U.S.C. Section 1350 Section 906 of the Sarbanes-Oxley Act of 2002 - Chief Executive Officer
32.2**   Certification pursuant to 18 U.S.C. Section 1350 Section 906 of the Sarbanes-Oxley Act of 2002 - Chief Financial Officer
101.INS*   Inline XBRL Instance Document
101.SCH*   Inline XBRL Taxonomy Extension Schema Document
101.CAL*   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE*   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104*   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

*Filed herewith.

 

** Furnished herewith

 

78

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  SURGEPAYS, INC.
Date: August 13, 2025    
  By: /s/ Kevin Brian Cox
    Kevin Brian Cox
   

Chief Executive Officer

(Principal Executive Officer)

 

Date: August 13, 2025 /s/ Anthony Evers
  Anthony Evers
  Chief Financial Officer
  (Principal Financial and Accounting Officer)

 

79

 

FAQ

What was SurgePays (SURGW) net loss for the six months ended June 30, 2025?

The company reported a net loss available to common stockholders of $14,717,682 for the six months ended June 30, 2025.

How much cash did SurgePays (SURGW) have on hand at June 30, 2025?

Cash and cash equivalents totaled $4,404,449 as of June 30, 2025.

Did SurgePays (SURGW) disclose a going concern issue?

Yes. Management disclosed substantial doubt about the company’s ability to continue as a going concern within the twelve months following issuance of the financial statements.

How did SurgePays (SURGW) generate revenue in the six months ended June 30, 2025?

Total revenue was $22,095,596, with $17,536,066 (79.36%) from Point-of-Sale and Prepaid Services and $4,559,530 (20.64%) from MVNO operations.

What financing activity occurred during the period for SurgePays (SURGW)?

The company reported proceeds of $6,000,000 from issuance of a convertible note payable and net cash provided by financing activities of $4,715,069 for the six months.

What is SurgePays' accumulated deficit and shareholders' equity position?

Accumulated deficit was $75,633,109, and total stockholders' equity was $61,392 at June 30, 2025.
Surgepays

NASDAQ:SURGW

SURGW Rankings

SURGW Latest News

SURGW Latest SEC Filings

SURGW Stock Data

13.39M
Software - Application
Telephone Communications (no Radiotelephone)
Link
United States
BARTLETT